[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_cddca74d-fad9-4b18-938b-1d868f16f556":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:cddca74d-fad9-4b18-938b-1d868f16f556,\"}":108},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":37,"indexDatabases":61,"url":18,"thumbnailPath":18,"statistic":102,"gsStatistic":18,"type":18,"analyzePriority":18},"cddca74d-fad9-4b18-938b-1d868f16f556","2024-04-07T08:44:04.651+00:00","2025-11-21T09:52:00.351+00:00",[],"Growth-Hormone-IGF-Research",{"issn":12,"title":14},{"VOID":13},"10966374",{"EN":15},"Growth Hormone & IGF Research","PUBLISHER","PENDING",null,0,[21,29],{"id":22,"createTime":23,"updateTime":24,"relativeEntities":25,"label":26,"description":28,"parentId":18,"standard":18,"scholarHubFieldId":18},"1af9c91a-59a8-48f8-b117-f75b9207cb09","2023-05-29T10:24:13.173+00:00","2023-11-21T07:47:43.788+00:00",[],{"EN":27},"Endocrinology, Diabetes and Metabolism",{},{"id":30,"createTime":31,"updateTime":32,"relativeEntities":33,"label":34,"description":36,"parentId":18,"standard":18,"scholarHubFieldId":18},"9d9ee0b8-275d-4715-80d5-b489aa93b426","2023-05-29T10:24:13.210+00:00","2023-11-21T07:48:23.810+00:00",[],{"EN":35},"Endocrinology",{},[38,50],{"id":39,"createTime":40,"updateTime":41,"relativeEntities":42,"slug":43,"properties":44,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":48,"url":18,"parentIds":49,"statistic":18},"cbc888ff-f0a8-49ab-90e6-8acb752d4f88","2023-05-29T10:24:05.444+00:00","2025-11-21T10:07:47.637+00:00",[],"Elsevier-Ltd-",{"title":45},{"EN":46},"Elsevier Ltd.","AFFILIATION",12,[],{"id":51,"createTime":52,"updateTime":53,"relativeEntities":54,"slug":55,"properties":56,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":59,"url":18,"parentIds":60,"statistic":18},"353f4a78-4364-4142-a6fb-e8ac89c7d65e","2023-05-29T10:31:29.110+00:00","2025-11-21T10:07:27.570+00:00",[],"Churchill-Livingstone",{"title":57},{"EN":58},"Churchill Livingstone",8,[],[62,82],{"id":63,"indexDatabase":64,"url":78,"indexYears":18,"academicFieldIds":79,"indexDatabaseRanking":18},"7d10c95f-9eeb-4c4d-8f18-5bf3b62aec3d",{"id":65,"createTime":66,"updateTime":67,"relativeEntities":68,"label":69,"description":71,"key":74,"publicationTags":75,"standard":18},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":70,"VI":70},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":72,"EN":73},"Cơ sở dữ liệu SCIE","SCIE database","scie",[76,77],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1096-6374",[80,81],"7fc7f180-3918-45ab-8bea-b2226f5d88f6","8eb75d88-0c7a-497c-a346-e729afc75040",{"id":83,"indexDatabase":84,"url":96,"indexYears":97,"academicFieldIds":98,"indexDatabaseRanking":101},"841294f8-95bd-4226-a3bc-eacac852eeaa",{"id":85,"createTime":86,"updateTime":87,"relativeEntities":88,"label":89,"description":91,"key":93,"publicationTags":94,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":90,"VI":90},"Scopus - Elsevier",{"EN":90,"VI":92},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[95],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F26116","1998-2025",[99,100],"5b134d7d-51cf-4eea-aade-eaec47ba2837","1fbd0674-a1cb-4227-af17-9260dd767b86","SCOPUS__Q2",{"impactFactor":19,"impactFactorByYear":103,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":105,"totalCitation":19,"totalCitationByYear":106,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":107,"hindexLast5Year":19,"hindex":19},{},1,{"2001":104},{},{},{"meta":109,"data":111},{"total":110},"680",[112,195,341,478,606,924,1013,1139,1268,1345],{"id":113,"createTime":114,"updateTime":115,"relativeEntities":116,"slug":117,"properties":118,"entityType":125,"verifyStatus":126,"verifyTime":115,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":128,"fullTextUrl":18,"authors":129,"publicationType":158,"publisherRelationship":159,"citationCount":18,"citationInfo":18,"publishDate":192,"publishYear":193,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"837f2ba6-8455-48d0-8356-4bbb7dd7dd23","2024-01-19T06:37:58.498+00:00","2024-12-05T23:58:39.845+00:00",[],"Endoplasmic-reticulum-calcium-storage-and-release-in-cells-expressing-misfolded-growth-hormone",{"references":119,"title":121,"doi":123},{"VOID":120},"Phillips, 1994, Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency, J. Clin. Endocrinol. Metab., 78, 11, 10.1210\u002Fjc.78.1.11\nCogan, 1995, A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency—a clinical research center study, J. Clin. Endocrinol. Metab., 80, 3591, 10.1210\u002Fjc.80.12.3591\nCogan, 1994, Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein, J. Clin. Endocrinol. Metab., 79, 1261, 10.1210\u002Fjc.79.5.1261\nde Vos, 1992, Human growth hormone and extracellular domain of its receptor: crystal structure of the complex, Science, 255, 306, 10.1126\u002Fscience.1549776\nLee, 2000, Autosomal dominant growth hormone (GH) deficiency type II: the Δ32–71-GH deletion mutant suppresses secretion of wild-type GH, Endocrinology, 141, 883, 10.1210\u002Fen.141.3.883\nGraves, 2001, Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic, J. Cell Sci., 114, 3685, 10.1242\u002Fjcs.114.20.3685\nL. McGuinness, C. Magoulas, K. Mathers, D. Carmignac, J.B. Manneville, H. Christian, J.A. Phillips III, I.C. Robinson, Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice, Endocrinology (in press)\nHoll, 1988, Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin, Endocrinology, 122, 2927, 10.1210\u002Fendo-122-6-2927\nSmith, 1997, Peptidomimetic regulation of growth hormone secretion, Endocr. Rev., 18, 621, 10.1210\u002Fer.18.5.621\nBerridge, 1993, Inositol trisphosphate and calcium signalling, Nature, 361, 315, 10.1038\u002F361315a0\nPaschen, 2001, Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states, Cell Calcium, 29, 1, 10.1054\u002Fceca.2000.0162\nLam, 1994, Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes, Proc. Natl. Acad. Sci. USA, 91, 6569, 10.1073\u002Fpnas.91.14.6569\nHe, 1997, Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl- 2, J. Cell Biol., 138, 1219, 10.1083\u002Fjcb.138.6.1219\nKatayama, 1999, Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response, Nat. Cell Biol., 1, 479, 10.1038\u002F70265\nKruman II, 1999, ALS-linked Cu\u002FZn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis, Exp. Neurol., 160, 28, 10.1006\u002Fexnr.1999.7190\nTsai, 1998, Adrenergic nerve smooth endoplasmic reticulum calcium buffering declines with age, Neurobiol. Aging, 19, 89, 10.1016\u002FS0197-4580(98)00008-6\nKohno, 1997, Neuroprotective nitric oxide synthase inhibitor reduces intracellular calcium accumulation following transient global ischemia in the gerbil, Neurosci. Lett., 224, 17, 10.1016\u002FS0304-3940(97)13459-0\nMiyawaki, 1997, Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin [see comments], Nature, 388, 882, 10.1038\u002F42264\nMiyawaki, 1999, Dynamic and quantitative Ca2+ measurements using improved cameleons, Proc. Natl. Acad. Sci. USA, 96, 2135, 10.1073\u002Fpnas.96.5.2135\nBygrave, 1996, What is the concentration of calcium ions in the endoplasmic reticulum?, Cell Calcium, 19, 547, 10.1016\u002FS0143-4160(96)90064-0\nHayashi, 1999, Inhibition of growth hormone (GH) secretion by a mutant GH-I gene product in neuroendocrine cells containing secretory granules: an implication for isolated GH deficiency inherited in an autosomal dominant manner, J. Clin. Endocrinol. Metab., 84, 2134, 10.1210\u002Fjc.84.6.2134\nKuznetsov, 1998, Folding of secretory and membrane proteins, N. Engl. J. Med., 339, 1688, 10.1056\u002FNEJM199812033392307\nPerlmutter, 1999, Misfolded proteins in the endoplasmic reticulum, Lab. Invest., 79, 623\nEllgaard, 1999, Setting the standards: quality control in the secretory pathway, Science, 286, 1882, 10.1126\u002Fscience.286.5446.1882\nKaushal, 1994, Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa, Biochemistry, 33, 6121, 10.1021\u002Fbi00186a011\nSung, 1993, Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain, J. Biol. Chem., 268, 26645, 10.1016\u002FS0021-9258(19)74360-9\nIto, 1997, Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum, J. Clin. Invest., 99, 1897, 10.1172\u002FJCI119357\nWu, 1994, A lag in intracellular degradation of mutant α1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency, Proc. Natl. Acad. Sci. USA, 91, 9014, 10.1073\u002Fpnas.91.19.9014\nChapman, 1998, Intracellular signaling from the endoplasmic reticulum to the nucleus, Annu. Rev. Cell Dev. Biol., 14, 459, 10.1146\u002Fannurev.cellbio.14.1.459\nKaufman, 1999, Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls, Genes Dev., 13, 1211, 10.1101\u002Fgad.13.10.1211\nMori, 2000, Tripartite management of unfolded proteins in the endoplasmic reticulum, Cell, 101, 451, 10.1016\u002FS0092-8674(00)80855-7\nSidrauski, 1998, The unfolded protein response: an intracellular signalling pathway with many surprising features, Trends Cell Biol., 8, 245, 10.1016\u002FS0962-8924(98)01267-7\nLipton, 1999, Ischemic cell death in brain neurons, Physiol. Rev., 79, 1431, 10.1152\u002Fphysrev.1999.79.4.1431\nPreston, 1997, Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression, Cancer Res., 57, 537\nBian, 1997, Poles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells, Am. J. Physiol., 272, C1241, 10.1152\u002Fajpcell.1997.272.4.C1241\nBerg, 1995, Kainic acid-induced seizures and brain damage in the rat: role of calcium homeostasis, J. Neurosci. Res., 40, 641, 10.1002\u002Fjnr.490400509\nYu, 1999, The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis, Exp. Neurol., 155, 302, 10.1006\u002Fexnr.1998.7002\nChiou, 1995, Prevention and reduction of neural damage in ischemic strokes by w-(N,N′-diethylamino)-n-alkyl-3,4,5-trimethoxybenzoate compounds, J. Pharmacol. Exp. Ther., 275, 474",{"EN":122},"Endoplasmic reticulum calcium storage and release in cells expressing misfolded growth hormone",{"VOID":124},"10.1016\u002Fs1096-6374(02)00120-x","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS109663740200120X",[130,146],{"id":131,"sortIndex":104,"researcher":18,"roles":132,"affiliations":134,"properties":143},"6e97bcde-96dc-4f8e-ac49-a5f646f34ba7",[133],"AUTHOR",[135],{"id":18,"sortIndex":19,"affiliation":136,"properties":18},{"id":137,"createTime":138,"updateTime":138,"relativeEntities":139,"slug":18,"properties":140,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"1fe02504-7a48-4849-8967-01743febb67d","2024-01-08T18:13:11.559+00:00",[],{"title":141},{"VI":142},"Department of Pharmacology and Physiology, University of Rochester Medical Center, Box 711, 601 Elmwood Avenue, Rochester, NY 14642, USA",{"title":144},{"VI":145},"Patricia M. Hinkle",{"id":147,"sortIndex":19,"researcher":18,"roles":148,"affiliations":149,"properties":155},"bca5d59f-f601-4173-b3e3-17f371da5532",[133],[150],{"id":18,"sortIndex":19,"affiliation":151,"properties":18},{"id":137,"createTime":138,"updateTime":138,"relativeEntities":152,"slug":18,"properties":153,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":154},{"VI":142},{"title":156},{"VI":157},"Thomas K. Graves","ARTICLE",{"url":128,"publisher":160,"properties":187},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":161,"slug":10,"properties":162,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":165,"manageAffiliations":166,"indexDatabases":167,"url":18,"thumbnailPath":18,"statistic":182,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":163,"title":164},{"VOID":13},{"EN":15},[],[],[168,175],{"id":83,"indexDatabase":169,"url":96,"indexYears":97,"academicFieldIds":174,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":170,"label":171,"description":172,"key":93,"publicationTags":173,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":176,"url":78,"indexYears":18,"academicFieldIds":181,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":177,"label":178,"description":179,"key":74,"publicationTags":180,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":183,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":184,"totalCitation":19,"totalCitationByYear":185,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":186,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":188,"pages":190},{"VOID":189},"13",{"VOID":191},"36-43","2003-02-01",2003,false,{"id":196,"createTime":197,"updateTime":197,"relativeEntities":198,"slug":18,"properties":199,"entityType":125,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":206,"fullTextUrl":18,"authors":207,"publicationType":158,"publisherRelationship":306,"citationCount":18,"citationInfo":18,"publishDate":339,"publishYear":340,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"7d111d9f-269c-4ef9-ba56-da32df40ac65","2024-01-16T23:56:08.567+00:00",[],{"references":200,"title":202,"doi":204},{"VOID":201},"Mega, 1999, The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease, Arch. Neurol., 56, 1388, 10.1001\u002Farchneur.56.11.1388\nGiacobini, 2000, Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer’s disease, Alzheimer Dis. Assoc. Disord., 14 suppl 1, S3, 10.1097\u002F00002093-200000001-00002\nAlhainen, 1993, The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer’s disease, J. Neural. Transm. Park. Dis. Dement. Sect., 5, 185, 10.1007\u002FBF02257673\nSchneider, 1991, Do blood pressure and age predict response to tacrine (THA) in Alzheimer’s disease? A preliminary report, Psychopharmacol. Bull., 27, 309\nFarlow, 1998, Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer’s disease, Neurology, 50, 669, 10.1212\u002FWNL.50.3.669\nAlhainen, 1993, Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy, Acta Neurol. Scand., 149, 16\nKaufer, 1996, Effect of tacrine on behavioral symptoms in Alzheimer’s disease: An open-label study, J. Geriatr. Psychiat. Neurol., 9, 1, 10.1177\u002F089198879600900101\nFarlow, 2001, Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression, Arch. Neurol., 58, 417, 10.1001\u002Farchneur.58.3.417\nMega, 2000, Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer’s disease, J. Neuropsych. Clin. Neurosci., 12, 209, 10.1176\u002Fappi.neuropsych.12.2.209\nTanaka, 2003, Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer’s disease patients, Dement. Geriatr. Cogn. Disord., 16, 119, 10.1159\u002F000070998\nBlasko, 2004, Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions, Pharmacology, 72, 1, 10.1159\u002F000078625\nDik, 2003, Insulin-like growth factor I (IGF-I) and cognitive decline in older persons, Neurobiol. Aging, 24, 573, 10.1016\u002FS0197-4580(02)00136-7\nGarcia, 2006, Association of insulin-like growth factor-1 receptor polymorphism in dementia, Dement. Geriatr. Cogn. Disord., 22, 439, 10.1159\u002F000095803\nCarro, 2004, The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s disease, Eur. J. Pharmacol., 490, 127, 10.1016\u002Fj.ejphar.2004.02.050\nGasparini, 2003, Potential roles of insulin and IGF-I in Alzheimer’s disease, Trend Neurosci., 26, 404, 10.1016\u002FS0166-2236(03)00163-2\nWatanabe, 2005, Relationship between serum insulin-like growth factor-1 levels and Alzheimer’s disease and vascular dementia, J. Am. Geriatr. Soc., 53, 1748, 10.1111\u002Fj.1532-5415.2005.53524.x\nMatsui, 1999, Absorption, distribution, metabolism, and excretion of donepezil (aricept) after a single oral administration to rat, Drug Metab. Dispos., 27, 1406\nRivera, 2005, Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine, J. Alzheimer Dis., 8, 247, 10.3233\u002FJAD-2005-8304\nMcKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology, 34, 939, 10.1212\u002FWNL.34.7.939\nFolstein, 1975, Mini-mental state: a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016\u002F0022-3956(75)90026-6\nHughes, 1982, A new clinical scale for the staging of dementia, Br. J. Psychiatr., 140, 566, 10.1192\u002Fbjp.140.6.566\nReisberg, 1988, Functional assessment staging (FAST), Psychopharmacol. Bull., 24, 653\nHonma, 1991, Development of a new rating scale for dementia in the elderly: mental function impairment scale (MENFIS), Jap. J. Geriatr. Psychiatr., 2, 1217\nG.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings J.C. Masdeu, P. Scheinberg, Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop, Neurology, 43, 1993, pp. 250–260.\nSands, 1999, Assessment individual patients for cognitive benefits from acetylcholinesterase inhibitors, Alzheimer Dis. Assoc. Disord., 13, 26, 10.1097\u002F00002093-199903000-00004\nYamamoto, 2005, High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia, J. Am. Geriatric. Soc., 53, 583, 10.1111\u002Fj.1532-5415.2005.53204.x\nWatanabe, 2003, Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis, Am. J. Hypertens., 16, 754, 10.1016\u002FS0895-7061(03)00985-3\nArwert, 2005, The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis, Growth Horm. IGF Res., 15, 416, 10.1016\u002Fj.ghir.2005.09.001\nPaolisso, 1997, Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centanarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function, J. Clin. Endocrinol. Metab., 82, 2204, 10.1210\u002Fjc.82.7.2204\nOkereke, 2007, Plasma IGF-1 levels and cognitive performance in older women, Neurobiol. Aging, 28, 135, 10.1016\u002Fj.neurobiolaging.2005.10.012\nLandi, 2007, Free insulin-like growth factor-I and cognitive function in older persons living in community, Growth Horm. IGF Res., 17, 58, 10.1016\u002Fj.ghir.2006.11.001\nSchulingkamp, 2000, Insulin receptors and insulin action in the brain review and clinical implications, Neurosci. Biobehav. Rev., 24, 855, 10.1016\u002FS0149-7634(00)00040-3\nCastro-Alamancos, 1994, Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide, Proc. Natl. Acad. Sci. USA, 91, 10203, 10.1073\u002Fpnas.91.21.10203\nGluckman, 1992, A role for IGF-1 in the rescure of CNS neurons following hypoxic\u002Fischemic injury, Biochem. Biophys. Res. Commun., 182, 593, 10.1016\u002F0006-291X(92)91774-K\nWu, 1996, Activation of the I-LGF-1 receptor inhibits tumor necrosis factor-induced cell death, J. Cell Physiol., 168, 499, 10.1002\u002F(SICI)1097-4652(199609)168:3\u003C499::AID-JCP2>3.0.CO;2-K\nCarro, 2002, Serum insulin-like growth factor-I regulates brain amyroid-β levels, Nat. Med., 8, 1390, 10.1038\u002Fnm1202-793\nCarro, 2006, Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer’s-like neuropathology in rodents: new cues into the human disease?, Neurobiol. Aging, 27, 1618, 10.1016\u002Fj.neurobiolaging.2005.09.039\nSteen, 2005, Impaired insulin and insulin-like growth factor expression and signalling mechanisms in Alzheimer’s disease-is this type 3 diabetes?, J. Alzheimer Dis., 7, 63, 10.3233\u002FJAD-2005-7107\nMustafa, 1999, Decreased plasma insulin-like growth factor-I level in familial Alzheimer’s disease patients carrying the Swedish APP 670\u002F671 mutation, Dement. Geriatr. Cogn. Disord., 10, 446, 10.1159\u002F000017188\nAlvarez, 2007, Serum TNF-alpha levels are increased and correlated negatively with free IGF-I in Alzheimer disease, Neurobiol. Aging, 28, 533, 10.1016\u002Fj.neurobiolaging.2006.02.012\nLombardi, 1999, Characterization of cytokine production screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer’s disease individuals, J. Neuroimmunol., 97, 163, 10.1016\u002FS0165-5728(99)00046-6\nKinoshita, 2007, The relationship in Japanese infants between a genetic polymorphism in the promoter region of the insulin-like growth factor I gene and the plasma level, Neonatology, 92, 116, 10.1159\u002F000101062\nHarada, 2007, Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans, Growth Horm. IGF Res., 17, 171, 10.1016\u002Fj.ghir.2006.12.005\nObermayr, 2005, The age-related down-regulation of the growth hormone\u002Finsulin-like growth factors-I axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer’s disease, Exp. Gerontol., 40, 157, 10.1016\u002Fj.exger.2004.11.001\nJones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3\nVignery, 1996, The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts, Bone, 18, 331, 10.1016\u002F8756-3282(96)00017-8\nHarada, 2005, Contribution of capsaicin-sensitive sensory neurons to antithrombin-induced reduction of ischemia\u002Freperfusion-induced liver injury in rats, Thromb. Haemost., 93, 48, 10.1160\u002FTH04-02-0106\nHarada, 2007, Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I thereby reducing reperfusion-induced apoptosis in mice, Neuropharmacology, 52, 1303, 10.1016\u002Fj.neuropharm.2007.01.016\nTanaka, 2004, Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer’s disease, J. Neurol. Sci., 225, 135, 10.1016\u002Fj.jns.2004.07.009\nWinblad, 2006, Severe Alzheimer’s disease study group, donepezil in patients with severe Alzheimer’s disease: double bond, parallel-group, placebo-controlled study, Lancet, 367, 1057, 10.1016\u002FS0140-6736(06)68350-5",{"EN":203},"Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer’s disease",{"VOID":205},"10.1016\u002Fj.ghir.2007.07.006","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637407000925",[208,224,236,252,268,281,294],{"id":209,"sortIndex":210,"researcher":18,"roles":211,"affiliations":212,"properties":221},"5a5f51a7-0838-4fd0-b581-be66c2c55b23",5,[133],[213],{"id":18,"sortIndex":19,"affiliation":214,"properties":18},{"id":215,"createTime":216,"updateTime":216,"relativeEntities":217,"slug":18,"properties":218,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"22ea056b-5291-4cd8-aa3d-30983dfcb163","2024-01-16T23:56:08.590+00:00",[],{"title":219},{"VI":220},"Department of Neuropsychiatry, Showa University School of Medicine, Tokyo 142-0054, Japan",{"title":222},{"VI":223},"Nobumasa Kato",{"id":225,"sortIndex":104,"researcher":18,"roles":226,"affiliations":227,"properties":233},"cd5a7895-6042-4fe1-bd2b-7fa94d8f1115",[133],[228],{"id":18,"sortIndex":19,"affiliation":229,"properties":18},{"id":215,"createTime":216,"updateTime":216,"relativeEntities":230,"slug":18,"properties":231,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":232},{"VI":220},{"title":234},{"VI":235},"Hideki Yamamoto",{"id":237,"sortIndex":238,"researcher":18,"roles":239,"affiliations":240,"properties":249},"631ca4f6-2962-4032-85d5-f4831c46df5f",2,[133],[241],{"id":18,"sortIndex":19,"affiliation":242,"properties":18},{"id":243,"createTime":244,"updateTime":244,"relativeEntities":245,"slug":18,"properties":246,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"55117766-b64b-4268-85bd-b4b6a4c5a88d","2024-01-16T23:56:08.618+00:00",[],{"title":247},{"VI":248},"Department of Biochemistry, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan",{"title":250},{"VI":251},"Takuya Watanabe",{"id":253,"sortIndex":254,"researcher":18,"roles":255,"affiliations":256,"properties":265},"9167e157-ad70-4521-a0a5-15f21232d9eb",4,[133],[257],{"id":18,"sortIndex":19,"affiliation":258,"properties":18},{"id":259,"createTime":260,"updateTime":260,"relativeEntities":261,"slug":18,"properties":262,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"f94b39d9-6d75-4f38-9fa4-4b301ace3b34","2024-01-16T23:56:08.646+00:00",[],{"title":263},{"VI":264},"Department of Hygiene and Preventive Medicine, Showa University School of Medicine, Tokyo 142-8555, Japan",{"title":266},{"VI":267},"Toshio Nakadate",{"id":269,"sortIndex":270,"researcher":18,"roles":271,"affiliations":272,"properties":278},"c7e448a4-34d0-468a-8d89-77ef1f1a2b1b",6,[133],[273],{"id":18,"sortIndex":19,"affiliation":274,"properties":18},{"id":215,"createTime":216,"updateTime":216,"relativeEntities":275,"slug":18,"properties":276,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":277},{"VI":220},{"title":279},{"VI":280},"Masaru Mimura",{"id":282,"sortIndex":283,"researcher":18,"roles":284,"affiliations":285,"properties":291},"9377803c-1cd0-4832-a376-1966bd6beadf",3,[133],[286],{"id":18,"sortIndex":19,"affiliation":287,"properties":18},{"id":243,"createTime":244,"updateTime":244,"relativeEntities":288,"slug":18,"properties":289,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":290},{"VI":248},{"title":292},{"VI":293},"Akira Miyazaki",{"id":295,"sortIndex":19,"researcher":18,"roles":296,"affiliations":297,"properties":303},"0214ec5d-864f-4883-8aec-cc6191f28d63",[133],[298],{"id":18,"sortIndex":19,"affiliation":299,"properties":18},{"id":215,"createTime":216,"updateTime":216,"relativeEntities":300,"slug":18,"properties":301,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":302},{"VI":220},{"title":304},{"VI":305},"Eitetsu Tei",{"url":206,"publisher":307,"properties":334},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":308,"slug":10,"properties":309,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":312,"manageAffiliations":313,"indexDatabases":314,"url":18,"thumbnailPath":18,"statistic":329,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":310,"title":311},{"VOID":13},{"EN":15},[],[],[315,322],{"id":83,"indexDatabase":316,"url":96,"indexYears":97,"academicFieldIds":321,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":317,"label":318,"description":319,"key":93,"publicationTags":320,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":323,"url":78,"indexYears":18,"academicFieldIds":328,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":324,"label":325,"description":326,"key":74,"publicationTags":327,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":330,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":331,"totalCitation":19,"totalCitationByYear":332,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":333,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":335,"pages":337},{"VOID":336},"18",{"VOID":338},"47-54","2008-02-01",2008,{"id":342,"createTime":343,"updateTime":344,"relativeEntities":345,"slug":346,"properties":347,"entityType":125,"verifyStatus":126,"verifyTime":344,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":354,"fullTextUrl":18,"authors":355,"publicationType":158,"publisherRelationship":443,"citationCount":18,"citationInfo":18,"publishDate":476,"publishYear":477,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"f967e89b-988e-4092-b414-fea71f226bc9","2024-01-20T10:27:02.078+00:00","2025-02-24T23:47:59.235+00:00",[],"Factors-and-markers-of-growth-hormone-secretion-and-gonadal-function-in-Fanconi-anemia",{"references":348,"title":350,"doi":352},{"VOID":349},"Alter, 2003, Inherited bone marrow failure syndromes, 280\nDupuis-Girod, 2001, Growth hormone deficiency caused by pituitary stalk interruption in Fanconi’s anemia, J. Pediatr., 138, 129, 10.1067\u002Fmpd.2001.109200\nSoulier, 2005, Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA\u002FBRCA pathway, Blood, 105, 1329, 10.1182\u002Fblood-2004-05-1852\nLeroy, 1971, A propos du poids et de la taille des nouveau-nés à la naissance, Rev. Franç. Gynécol., 66, 391\nAndersson, 1997, Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels, J. Clin. Endocrinol. Metab., 82, 3976, 10.1210\u002Fjc.82.12.3976\nAndersson, 1998, Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men, J. Clin. Endocrinol. Metab., 83, 675, 10.1210\u002Fjc.83.2.675\nSeminara, 1996, Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after short term GnRH replacement – a clinical research center study, J. Clin. Endocrinol. Metab., 81, 3692, 10.1210\u002Fjc.81.10.3692\nRey, 1999, Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement, J. Clin. Endocrinol. Metab., 84, 627, 10.1210\u002Fjc.84.2.627\nGiampetro, 1993, The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry, Pediatrics, 91, 1116, 10.1542\u002Fpeds.91.6.1116\nClarke, 1975, Growth hormone deficiency and Fanconi anemia, J. Pediatr., 86, 814, 10.1016\u002FS0022-3476(75)80385-4\nButturini, 1994, Short stature, Fanconi’s anemia, and risk of leukaemia after growth hormone therapy, Lancet, 343, 1576, 10.1016\u002FS0140-6736(94)92980-7\nPochedly, 1971, Fanconi’s anemia with growth hormone deficiency, J. Pediatr., 79, 93, 10.1016\u002FS0022-3476(71)80064-1\nZachmann, 1972, Fanconi’s anemia with isolated growth hormone deficiency, J. Pediatr., 80, 159, 10.1016\u002FS0022-3476(72)80485-2\nCostin, 1972, Fanconi’s anemia associated with isolated growth hormone deficiency, Clin. Res., 20, 253\nStubbe, 1975, Fanconi’s anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease?, Acta Paediatr. Scand., 64, 790, 10.1111\u002Fj.1651-2227.1975.tb03925.x\nGleadhill, 1975, Fanconi’s aplastic anemia with short stature. Absence of response to human growth hormone, Arch. Dis. Child., 50, 318, 10.1136\u002Fadc.50.4.318\nAynsley-Green, 1978, Endocrine studies in Fanconi’s anaemia. Report of 4 cases, Arch. Dis. Child., 53, 126, 10.1136\u002Fadc.53.2.126\nNordan, 1979, Fanconi’s anemia with growth hormone deficiency, Am. J. Dis. Child., 133, 291\nSchoof, 2000, Growth hormone deficiency in one of two siblings with Fanconi anaemia complementation group FA-D, Growth Horm. IGF Res., 10, 290, 10.1054\u002Fghir.2000.0164\nMassa, 2002, Hypergonadotropic hypogonadism in a boy with Fanconi anemia with growth hormone deficiency and pituitary stalk interruption, J. Pediatr., 140, 277, 10.1067\u002Fmpd.2002.119174\nAlter, 2003, Cancer in Fanconi anemia, Blood, 101, 2072, 10.1182\u002Fblood-2002-11-3597\nDe Chadarevian, 1985, Fanconi’s anemia, medulloblastoma, Wilms’ tumor, horshoe kidney and gonadal dysgenesis, Arch. Pathol. Lab. Med., 109, 367\nStanden, 1989, Myelodysplasic syndrome with trisomy 8 in an adolescent with Fanconi anaemia and selective IgA deficiency, Am. J. Hematol., 31, 280, 10.1002\u002Fajh.2830310413\nWada, 1989, Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi’s anemia, Jpn. J. Clin. Oncol., 19, 36\nAllen, 1997, Risk of leukemia in children treated with human growth hormone: review and reanalysis, J. Pediatr., 131, S32, 10.1016\u002FS0022-3476(97)70008-8\nBrauner, 1997, Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation, J. Pediatr., 130, 785, 10.1016\u002FS0022-3476(97)80022-4\nWajnrajch, 2001, Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry, Pediatrics, 107, 744, 10.1542\u002Fpeds.107.4.744\nCouto-Silva, 2001, Factors affecting gonadal function after bone marrow transplantation during childhood, Bone Marrow Transpl., 28, 67, 10.1038\u002Fsj.bmt.1703089\nNadler, 2002, Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells, Genesis, 27, 117, 10.1002\u002F1526-968X(200007)27:3\u003C117::AID-GENE40>3.0.CO;2-7",{"EN":351},"Factors and markers of growth hormone secretion and gonadal function in Fanconi anemia",{"VOID":353},"10.1016\u002Fj.ghir.2006.12.007","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637407000044",[356,371,386,401,413,428],{"id":357,"sortIndex":19,"researcher":18,"roles":358,"affiliations":359,"properties":368},"1a8c8560-94c4-4fb2-a766-60435989fcce",[133],[360],{"id":18,"sortIndex":19,"affiliation":361,"properties":18},{"id":362,"createTime":363,"updateTime":363,"relativeEntities":364,"slug":18,"properties":365,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"e5406bbf-b5ac-419d-a7b3-f421ecf602b0","2024-01-20T10:27:02.097+00:00",[],{"title":366},{"VI":367},"AP-HP, Hôpital Necker-Enfants Malades, Service d’Explorations Fonctionnelles, 75743 Paris, France",{"title":369},{"VI":370},"Christine Trivin",{"id":372,"sortIndex":210,"researcher":18,"roles":373,"affiliations":374,"properties":383},"f6040832-27fd-4418-9aed-6b407adb440e",[133],[375],{"id":18,"sortIndex":19,"affiliation":376,"properties":18},{"id":377,"createTime":378,"updateTime":378,"relativeEntities":379,"slug":18,"properties":380,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"8233ee30-68fc-462a-850b-8222df048023","2024-02-02T06:10:55.129+00:00",[],{"title":381},{"VI":382},"Université Paris-Descartes, 75270 Paris cedex 06, France",{"title":384},{"VI":385},"Raja Brauner",{"id":387,"sortIndex":254,"researcher":18,"roles":388,"affiliations":389,"properties":398},"8ebbe407-15f4-4da7-a973-e725e7f9a149",[133],[390],{"id":18,"sortIndex":19,"affiliation":391,"properties":18},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":394,"slug":18,"properties":395,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"eb5950ff-f362-463c-99d4-59a584128a5a","2024-01-20T10:27:02.151+00:00",[],{"title":396},{"VI":397},"AP-HP, Hôpital Saint Louis, Laboratoire Central d’Hématologie, INSERM U728, Université Paris 7, Paris 75475, France",{"title":399},{"VI":400},"Jean Soulier",{"id":402,"sortIndex":283,"researcher":18,"roles":403,"affiliations":404,"properties":410},"ee685056-bf38-4e86-8c5e-01fff72e20de",[133],[405],{"id":18,"sortIndex":19,"affiliation":406,"properties":18},{"id":377,"createTime":378,"updateTime":378,"relativeEntities":407,"slug":18,"properties":408,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":409},{"VI":382},{"title":411},{"VI":412},"Marie-Noëlle Cousin",{"id":414,"sortIndex":104,"researcher":18,"roles":415,"affiliations":416,"properties":425},"66d4c6c2-50c0-4ae0-881b-8476fb3b610a",[133],[417],{"id":18,"sortIndex":19,"affiliation":418,"properties":18},{"id":419,"createTime":420,"updateTime":420,"relativeEntities":421,"slug":18,"properties":422,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"15c0528a-fb82-4701-b691-a64548d68f7a","2024-01-20T10:27:02.110+00:00",[],{"title":423},{"VI":424},"AP-HP, Hôpital Saint Louis, Service des Greffes de Moelle, Université Paris 7, 75475 Paris, France",{"title":426},{"VI":427},"Eliane Gluckman",{"id":429,"sortIndex":238,"researcher":18,"roles":430,"affiliations":431,"properties":440},"e2b7f9b7-a59f-4529-bc28-528c06715db8",[133],[432],{"id":18,"sortIndex":19,"affiliation":433,"properties":18},{"id":434,"createTime":435,"updateTime":435,"relativeEntities":436,"slug":18,"properties":437,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"97725979-de13-482d-82fa-4e65078fffec","2024-01-20T10:27:02.121+00:00",[],{"title":438},{"VI":439},"AP-HP, Hôpital Saint Louis, Service d’Hématologie Pédiatrique, 75475 Paris, France",{"title":441},{"VI":442},"Thierry Leblanc",{"url":354,"publisher":444,"properties":471},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":445,"slug":10,"properties":446,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":449,"manageAffiliations":450,"indexDatabases":451,"url":18,"thumbnailPath":18,"statistic":466,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":447,"title":448},{"VOID":13},{"EN":15},[],[],[452,459],{"id":83,"indexDatabase":453,"url":96,"indexYears":97,"academicFieldIds":458,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":454,"label":455,"description":456,"key":93,"publicationTags":457,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":460,"url":78,"indexYears":18,"academicFieldIds":465,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":461,"label":462,"description":463,"key":74,"publicationTags":464,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":467,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":468,"totalCitation":19,"totalCitationByYear":469,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":470,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":472,"pages":474},{"VOID":473},"17",{"VOID":475},"122-129","2007-04-01",2007,{"id":479,"createTime":480,"updateTime":481,"relativeEntities":482,"slug":483,"properties":484,"entityType":125,"verifyStatus":126,"verifyTime":481,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":491,"fullTextUrl":18,"authors":492,"publicationType":158,"publisherRelationship":571,"citationCount":18,"citationInfo":18,"publishDate":604,"publishYear":605,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"1aa615de-821e-4656-825d-ed5c4a166e0c","2024-02-07T22:57:07.314+00:00","2024-10-10T23:45:55.474+00:00",[],"Marked-reductions-in-bioactive-insulin-like-growth-factor-I-IGF-I-during-hemodialysis",{"references":485,"title":487,"doi":489},{"VOID":486},"Bossola, 2005, Malnutrition in hemodialysis patients: what therapy?, Am. J. Kidney Dis., 46, 371, 10.1053\u002Fj.ajkd.2005.05.031\nMahan, 2006, Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement, Pediatr. Nephrol., 21, 917, 10.1007\u002Fs00467-006-0020-y\nRabkin, 2005, Growth hormone resistance in uremia, a role for impaired JAK\u002FSTAT signaling, Pediatr. Nephrol., 20, 313, 10.1007\u002Fs00467-004-1713-8\nJones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3\nFrystyk, 1999, Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure, Kidney Int., 56, 2076, 10.1046\u002Fj.1523-1755.1999.00798.x\nGutierrez, 1992, Protein catabolism in sham-hemodialysis: the effect of different membranes, Clin. Nephrol., 38, 20\nIkizler, 2002, Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation, Am. J. Physiol. Endocrinol. Metab., 282, E107, 10.1152\u002Fajpendo.2002.282.1.E107\nLofberg, 2000, Effect of hemodialysis on protein synthesis, Clin. Nephrol., 54, 284\nRocco, 2004, The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO study, Kidney Int., 65, 2321, 10.1111\u002Fj.1523-1755.2004.00647.x\nFeldt-Rasmussen, 2007, Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk, J. Am. Soc. Nephrol., 18, 2161, 10.1681\u002FASN.2006111207\nJacob, 1990, IGF-I, a marker of undernutrition in hemodialysis patients, Am. J. Clin. Nutr., 52, 39, 10.1093\u002Fajcn\u002F52.1.39\nAxelsson, 2006, Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?, Eur. J. Clin. Nutr., 60, 718, 10.1038\u002Fsj.ejcn.1602373\nPupim, 2002, Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients, J. Clin. Invest., 110, 483, 10.1172\u002FJCI0215449\nCaufriez, 1993, Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels, J. Endocrinol. Invest., 16, 691, 10.1007\u002FBF03348913\nBohe, 2001, Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3, Nephrol. Dial. Transpl., 16, 590, 10.1093\u002Fndt\u002F16.3.590\nLindgren, 1996, Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?, Growth Regul., 6, 137\nFrystyk, 1995, Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II, Growth Regul., 5, 169\nFrystyk, 1994, Free insulin-like growth factors (IGF-I and IGF-II] in human serum, FEBS Lett., 348, 185, 10.1016\u002F0014-5793(94)00602-4\nKrassas, 2003, Free and total insulin-like growth factor (IGF]-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease, J. Clin. Endocrinol. Metab., 88, 132, 10.1210\u002Fjc.2002-021349\nFrystyk, 2002, Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum, J. Clin. Endocrinol. Metab., 87, 260, 10.1210\u002Fjc.87.1.260\nChen, 2003, A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum, Am. J. Physiol. Endocrinol. Metab., 284, E1149, 10.1152\u002Fajpendo.00410.2002\nChen, 2006, Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis, Eur. J. Endocrinol., 155, 285, 10.1530\u002Feje.1.02218\nChen, 2005, Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects, J. Clin. Endocrinol. Metab., 90, 366, 10.1210\u002Fjc.2004-0039\nSchwalbe, 1977, Somatomedin in growth disorders and chronic renal insufficiency in children, Brit. Med. J., 1, 679, 10.1136\u002Fbmj.1.6062.679\nPhillips, 1981, Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function, Metabolism, 30, 1091, 10.1016\u002F0026-0495(81)90053-6\nBlum, 1991, Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia, Pediatr. Nephrol., 5, 539, 10.1007\u002FBF01453697\nMøller, 2006, Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro, Eur. J. Endocrinol., 155, 297, 10.1530\u002Feje.1.02203\nBrismar, 1994, Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1], IGFBP-3, and IGF-I in insulin-dependent diabetes, J. Clin. Endocrinol. Metab., 79, 872, 10.1210\u002Fjc.79.3.872\nFrystyk, 2004, Free insulin-like growth factors – measurements and relationships to growth hormone secretion and glucose homeostasis, Growth Horm. IGF Res., 14, 337, 10.1016\u002Fj.ghir.2004.06.001\nAbe, 2007, Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose, Ther. Apher Dial., 11, 280, 10.1111\u002Fj.1744-9987.2007.00491.x\nLang, 2002, Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection, Curr. Opin. Clin. Nutr. Metab. Care, 5, 271, 10.1097\u002F00075197-200205000-00006\nHiguchi, 2004, A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production, Ther. Apher Dial., 8, 460, 10.1111\u002Fj.1774-9979.2004.00194.x\nSingh, 2003, Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study, Renal Fail., 25, 419, 10.1081\u002FJDI-120021154\nCarlstrom, 1990, Serum hormone levels in men with end stage renal disease, Scand. J. Urol. Nephrol., 24, 75, 10.3109\u002F00365599009180364\nWestwood, 1997, Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma, Endocrinology, 138, 1130, 10.1210\u002Fen.138.3.1130\nØrskov, 1982, Acetate: inhibitor of growth Hormone hypersecretion in Diabetic and non-diabetic uremic subjects, Acta Endocrinol. Copenh., 99, 551, 10.1530\u002Facta.0.0990551\nSchmitz, 1982, Inhibition of arginine- and hypoglycemia-induced growth hormone release by acetate in dialysed patients, Clin. Nephrol., 17, 70\nGiustina, 1998, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human, Endocr. Rev., 19, 717, 10.1210\u002Fer.19.6.717\nSanaka, 1994, IGF-I as an early indicator of malnutrition in patients with end- stage renal disease, Nephron, 67, 73, 10.1159\u002F000187891",{"EN":488},"Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis",{"VOID":490},"10.1016\u002Fj.ghir.2009.12.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637409001580",[493,508,520,535,547,559],{"id":494,"sortIndex":210,"researcher":18,"roles":495,"affiliations":496,"properties":505},"8f74df5c-9bd9-4210-9e97-679d4e97bc49",[133],[497],{"id":18,"sortIndex":19,"affiliation":498,"properties":18},{"id":499,"createTime":500,"updateTime":500,"relativeEntities":501,"slug":18,"properties":502,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9a915575-621f-47a7-8f19-ffb45c9aaa50","2024-02-07T22:57:07.370+00:00",[],{"title":503},{"VI":504},"Medical Research Laboratories, Clinical Institute of Medicine and Medical Department M (Diabetes and Endocrinology), Aarhus University Hospital, Aarhus Sygehus, DK-8000 Aarhus C, Denmark",{"title":506},{"VI":507},"Jan Frystyk",{"id":509,"sortIndex":283,"researcher":18,"roles":510,"affiliations":511,"properties":517},"ebd9ce1b-7cad-4197-81a8-c06bd6c29493",[133],[512],{"id":18,"sortIndex":19,"affiliation":513,"properties":18},{"id":499,"createTime":500,"updateTime":500,"relativeEntities":514,"slug":18,"properties":515,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":516},{"VI":504},{"title":518},{"VI":519},"Jens Sandahl Christiansen",{"id":521,"sortIndex":238,"researcher":18,"roles":522,"affiliations":523,"properties":532},"efff51db-f091-46c8-90fc-539281dd2769",[133],[524],{"id":18,"sortIndex":19,"affiliation":525,"properties":18},{"id":526,"createTime":527,"updateTime":527,"relativeEntities":528,"slug":18,"properties":529,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"d273d072-9005-4007-9473-470b6a3c6bdd","2024-02-07T22:57:07.357+00:00",[],{"title":530},{"VI":531},"Department of Renal Medicine C, Aarhus University Hospital, Skejby Sygehus, DK-8200 Aarhus N, Denmark",{"title":533},{"VI":534},"Ida Tietze",{"id":536,"sortIndex":104,"researcher":18,"roles":537,"affiliations":538,"properties":544},"d1154a42-292c-4110-9d8f-6eb17e645d29",[133],[539],{"id":18,"sortIndex":19,"affiliation":540,"properties":18},{"id":499,"createTime":500,"updateTime":500,"relativeEntities":541,"slug":18,"properties":542,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":543},{"VI":504},{"title":545},{"VI":546},"Jian-Wen Chen",{"id":548,"sortIndex":19,"researcher":18,"roles":549,"affiliations":550,"properties":556},"4cc996e0-4100-47e2-b196-90856013e0b0",[133],[551],{"id":18,"sortIndex":19,"affiliation":552,"properties":18},{"id":526,"createTime":527,"updateTime":527,"relativeEntities":553,"slug":18,"properties":554,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":555},{"VI":531},{"title":557},{"VI":558},"Per Ivarsen",{"id":560,"sortIndex":254,"researcher":18,"roles":561,"affiliations":562,"properties":568},"be4e3215-e736-4fde-a2f6-f3fc3beaf9c2",[133],[563],{"id":18,"sortIndex":19,"affiliation":564,"properties":18},{"id":499,"createTime":500,"updateTime":500,"relativeEntities":565,"slug":18,"properties":566,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":567},{"VI":504},{"title":569},{"VI":570},"Allan Flyvbjerg",{"url":491,"publisher":572,"properties":599},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":573,"slug":10,"properties":574,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":577,"manageAffiliations":578,"indexDatabases":579,"url":18,"thumbnailPath":18,"statistic":594,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":575,"title":576},{"VOID":13},{"EN":15},[],[],[580,587],{"id":83,"indexDatabase":581,"url":96,"indexYears":97,"academicFieldIds":586,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":582,"label":583,"description":584,"key":93,"publicationTags":585,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":588,"url":78,"indexYears":18,"academicFieldIds":593,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":589,"label":590,"description":591,"key":74,"publicationTags":592,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":595,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":596,"totalCitation":19,"totalCitationByYear":597,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":598,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":600,"pages":602},{"VOID":601},"20",{"VOID":603},"156-161","2010-04-01",2010,{"id":607,"createTime":608,"updateTime":609,"relativeEntities":610,"slug":611,"properties":612,"entityType":125,"verifyStatus":126,"verifyTime":619,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":620,"fullTextUrl":18,"authors":621,"publicationType":158,"publisherRelationship":889,"citationCount":18,"citationInfo":18,"publishDate":922,"publishYear":923,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"41a49dd1-720f-4526-a6d8-d9e9a0fbf5fb","2023-12-06T15:34:51.395+00:00","2025-02-02T23:41:49.647+00:00",[],"Crosstalk-between-the-growth-hormone-insulin-like-growth-factor-1-axis-and-the-gut-microbiome-A-new-frontier-for-microbial-endocrinology",{"references":613,"title":615,"doi":617},{"VOID":614},"Troike, 2017, Impact of growth hormone on regulation of adipose tissue, Compr. Physiol., 7, 819, 10.1002\u002Fcphy.c160027\nBratusch-Marrain, 1981, Antidiabetic action of Somatostatin after Oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?, Horm. Metab. Res., 13, 305, 10.1055\u002Fs-2007-1019253\nDorchester, 1953, The effect of anterior pituitary extracts, desiccated thyroid, growth-hormone preparations and ACTH on the extractable secretin of the intestines of hypophysectomized and intact rats, J. Physiol., 119, 266, 10.1113\u002Fjphysiol.1953.sp004845\nLeblond, 1955, The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rat, Endocrinology, 56, 261, 10.1210\u002Fendo-56-3-261\nByrne, 1995, Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome, JPEN J. Parenter. Enteral Nutr., 19, 296, 10.1177\u002F0148607195019004296\nKaymakci, 2014, Protective effects of growth hormone on bacterial translocation and intestinal damage in rats with partial intestinal obstruction, Brat. Med. J., 115, 395, 10.4149\u002FBLL_2014_078\nYoung, 2019, Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse, Growth Hormon. IGF Res., 46-47, 5, 10.1016\u002Fj.ghir.2019.05.001\nYakar, 2015\nPereira-Fantini, 2008, Colostrum supplementation restores insulin-like growth factor −1 levels and alters muscle morphology following massive small bowel resection, JPEN J. Parenter. Enteral Nutr., 32, 266, 10.1177\u002F0148607108316197\nScopa, 2000, Beneficial effects of growth hormone and insulin-like growth factor I on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats, J. Am. Coll. Surg., 190, 423, 10.1016\u002FS1072-7515(99)00285-9\nSender, 2016, Revised estimates for the number of human and Bacteria cells in the body, PLoS Biol., 14, 10.1371\u002Fjournal.pbio.1002533\nBäckhed, 2012, Defining a Healthy human gut microbiome: current concepts, future directions, and clinical applications, Cell Host Microbe, 12, 611, 10.1016\u002Fj.chom.2012.10.012\nTurnbaugh, 2007, The human microbiome project: exploring the microbial part of ourselves in a changing world, Nature, 449, 804, 10.1038\u002Fnature06244\nRastelli, 2019, The gut microbiome influences host Endocrine functions, Endocr. Rev., 40, 1271, 10.1210\u002Fer.2018-00280\nBrunkwall, 2017, The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities, Diabetologia, 60, 943, 10.1007\u002Fs00125-017-4278-3\nSommer, 2013, The gut microbiota — masters of host development and physiology, Nat. Rev. Micro., 11, 227, 10.1038\u002Fnrmicro2974\nNeuman, 2015, Microbial endocrinology: the interplay between the microbiota and the endocrine system, FEMS Microbiol. Rev., 39, 509, 10.1093\u002Ffemsre\u002Ffuu010\nOliphant, 2019, Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health, Microbiome, 7, 10.1186\u002Fs40168-019-0704-8\nYan, 2017, Gut microbiome and bone: to build, destroy, or both?, Curr. Osteoporos Rep., 15, 376, 10.1007\u002Fs11914-017-0382-z\nPoinsot, 2018, The emerging connections between IGF1, the intestinal microbiome, Lactobacillus strains and bone growth, J. Mol. Endocrinol., 61, T103, 10.1530\u002FJME-17-0292\nSchwarzer, 2018, Gut microbiota: puppeteer of the host juvenile growth, Curr. Opin. Clin. Nutr. Metab. Care, 21, 179, 10.1097\u002FMCO.0000000000000463\nShortt, 2018, Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients, Eur. J. Nutr., 57, 25, 10.1007\u002Fs00394-017-1546-4\nMoore, 1946, Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick, J. Biol. Chem., 165, 437, 10.1016\u002FS0021-9258(17)41154-9\nStokstad, 1949, The multiple nature of the animal protein factor, J. Biol. Chem., 180, 647, 10.1016\u002FS0021-9258(18)56683-7\nMartin, 1942, P-Aminobenzoic acid and sulfonamides in rat nutrition, Exp. Biol. Med., 51, 56, 10.3181\u002F00379727-51-13825\nMikkelsen, 2016, Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature, Diabetes Obes. Metab., 18, 444, 10.1111\u002Fdom.12637\nPodolsky, 2017, Historical perspective on the rise and fall and rise of antibiotics and human weight gain, Ann. Intern. Med., 166, 133, 10.7326\u002FM16-1855\nEyssen, 1963, The mode of action of antibiotics in stimulating growth of chicks, J. Exp. Med., 117, 127, 10.1084\u002Fjem.117.1.127\nSieburth, 1951, Effect of antibiotics on intestinal microflora and on growth of turkeys and pigs, Proc. Soc. Exp. Biol. Med., 76, 15, 10.3181\u002F00379727-76-18375\nLane, 2011, Randomised clinical trial: helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study, Aliment. Pharmacol. Ther., 33, 922, 10.1111\u002Fj.1365-2036.2011.04610.x\nMackay, 1956, The influence of vitamin B12 and aureomycin upon the growth of protein-deficient children, J. Nutr., 59, 155, 10.1093\u002Fjn\u002F59.1.155\nLoughlin, 1957, Correction of simple growth failure in tropical children with low-level doses of oxytetracycline and lysine, Antibiot. Annu., 5, 99\nAzad, 2014, Infant antibiotic exposure and the development of childhood overweight and central adiposity, Int. J. Obes., 38, 1290, 10.1038\u002Fijo.2014.119\nSmith, 1902, Report LXXIII: on the growth of bacteria in the intestine, Br. Med. J., 2, 1941, 10.1136\u002Fbmj.2.2191.1941\nSchieber, 2015, Disease tolerance mediated by commensal E. coli via inflammasome and IGF-1 signaling, Science, 350, 558, 10.1126\u002Fscience.aac6468\nLan, 2017, Effects of Enterococcus faecium SLB 120 on growth performance, blood parameters, relative organ weight, breast muscle meat quality, excreta microbiota shedding, and noxious gas emission in broilers, Poult. Sci., 96, 3246, 10.3382\u002Fps\u002Fpex101\nLan, 2017, Effects of Lactobacillus acidophilus supplementation on growth performance, nutrient digestibility, fecal microbial and noxious gas emission in weaning pigs, J. Sci. Food Agric., 97, 1310, 10.1002\u002Fjsfa.7866\nLan, 2017, Effects of probiotic supplementation in different nutrient density diets on growth performance, nutrient digestibility, blood profiles, fecal microflora and noxious gas emission in weaning pig, J. Sci. Food Agric., 97, 1335, 10.1002\u002Fjsfa.7871\nTurnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038\u002Fnature05414\nSanz, 2010, Gut microbiota in obesity and metabolic disorders, Proc. Nutr. Soc., 69, 434, 10.1017\u002FS0029665110001813\nForbes, 2018, Association of exposure to formula in the hospital and subsequent infant feeding practices with gut microbiota and risk of overweight in the first year of life, JAMA Pediatr., 172, 10.1001\u002Fjamapediatrics.2018.1161\nBaumann-Dudenhoeffer, 2018, Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes, Nat. Med., 24, 1822, 10.1038\u002Fs41591-018-0216-2\nStewart, 2018, Temporal development of the gut microbiome in early childhood from the TEDDY study, Nature, 562, 583, 10.1038\u002Fs41586-018-0617-x\nNovince, 2017, Commensal gut microbiota Immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health, Sci. Rep., 7, 10.1038\u002Fs41598-017-06126-x\nSjogren, 2012, The gut microbiota regulates bone mass in mice, J. Bone Miner. Res., 27, 1357, 10.1002\u002Fjbmr.1588\nHsu, 2018, From osteoimmunology to osteomicrobiology: how the microbiota and the immune system regulate bone, Calcif. Tissue Int., 102, 512, 10.1007\u002Fs00223-017-0321-0\nOhlsson, 2017, Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling, Cell. Immunol., 317, 55, 10.1016\u002Fj.cellimm.2017.05.003\nSchwarzer, 2016, Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition, Science, 351, 854, 10.1126\u002Fscience.aad8588\nYan, 2016, Gut microbiota induce IGF-1 and promote bone formation and growth, Proc. Natl. Acad. Sci. U. S. A., 113, E7554, 10.1073\u002Fpnas.1607235113\nHathaway-Schrader, 2019, Antibiotic perturbation of gut microbiota dysregulates osteoimmune cross talk in postpubertal skeletal development, Am. J. Pathol., 189, 370, 10.1016\u002Fj.ajpath.2018.10.017\nBlanton, 2016, Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics, Science, 352, 1533, 10.1126\u002Fscience.aad9359\nWright, 2015, Recent advances in characterizing the gastrointestinal microbiome in Crohn’s disease: a systematic review, Inflamm. Bowel Dis., 21, 1219\nAurigemma, 2018, Linking the gut microbiota to bone health in anorexia nervosa, Curr. Osteoporos. Rep., 16, 65, 10.1007\u002Fs11914-018-0420-5\nChen, 2016, Altered gut microbiota in female mice with persistent low body weights following removal of post-weaning chronic dietary restriction, Genome Med., 8, 10.1186\u002Fs13073-016-0357-1\nSubramanian, 2014, Persistent gut microbiota immaturity in malnourished Bangladeshi children, Nature, 510, 417, 10.1038\u002Fnature13421\nAlou, 2017, Gut Bacteria missing in severe acute malnutrition, can we identify potential probiotics by Culturomics?, Front. Microbiol., 8\nPekmez, 2019, Gut microbiota alterations and dietary modulation in childhood malnutrition - the role of short chain fatty acids, Clin. Nutr., 38, 615, 10.1016\u002Fj.clnu.2018.02.014\nHoffman, 2017, Microbiome, growth retardation and metabolism: are they related?, Ann. Hum. Biol., 44, 201, 10.1080\u002F03014460.2016.1267261\nChiodini, 2015, Microbial population differentials between mucosal and submucosal intestinal tissues in advanced Crohn’s disease of the ileum, PLoS One, 10, 10.1371\u002Fjournal.pone.0134382\nLahad, 2015, Current therapy of pediatric Crohn’s disease, World J. Gastrointest. Pathophysiol., 6, 33, 10.4291\u002Fwjgp.v6.i2.33\nVatanen, 2018, The human gut microbiome in early-onset type 1 diabetes from the TEDDY study, Nature, 562, 589, 10.1038\u002Fs41586-018-0620-2\nZhao, 2018, Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes, Science, 359, 1151, 10.1126\u002Fscience.aao5774\nMurugesan, 2018, Gut microbiome production of short-chain fatty acids and obesity in children, Eur. J. Clin. Microbiol. Infect. Dis., 37, 621, 10.1007\u002Fs10096-017-3143-0\nNambam, 2018, Growth hormone and insulin-like growth factor-I axis in type 1 diabetes, Growth Hormon. IGF Res., 38, 49, 10.1016\u002Fj.ghir.2017.12.005\nSoendergaard, 2017, Growth hormone resistance—special focus on inflammatory bowel disease, Int. J. Mol. Sci., 18, 10.3390\u002Fijms18051019\nHan, 2007, Tumour necrosis factor α blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis, Gut, 56, 73, 10.1136\u002Fgut.2006.094490\nSoendergaard, 2017, Characterization of growth hormone resistance in experimental and ulcerative colitis, Int. J. Mol. Sci., 18, 2046, 10.3390\u002Fijms18102046\nBerryman, 2013, The GH\u002FIGF-1 axis in obesity: pathophysiology and therapeutic considerations, Nat. Rev. Endocrinol., 9, 346, 10.1038\u002Fnrendo.2013.64\nKojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038\u002F45230\nCarro, 1997, Regulation of in vivo growth hormone secretion by leptin, Endocrinology, 138, 2203, 10.1210\u002Fendo.138.5.5238\nBurgus, 1973, Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone, Proc. Natl. Acad. Sci. U. S. A., 70, 684, 10.1073\u002Fpnas.70.3.684\nMuller, 1999, Neuroendocrine control of growth hormone secretion, Physiol. Rev., 79, 511, 10.1152\u002Fphysrev.1999.79.2.511\nAbizaid, 2020, Ghrelin Signaling: GOAT and GHS-R1a take a LEAP in complexity, Trends Endocrinol. Metab., 31, 107, 10.1016\u002Fj.tem.2019.09.006\nJavorsky, 2017, Hypothalamus and pituitary gland, vol. 10e\nGreen, 1995, The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7, Genome Res., 5, 5, 10.1101\u002Fgr.5.1.5\nBado, 1998, The stomach is a source of leptin, Nature, 394, 790, 10.1038\u002F29547\nSharan, 2014, Hypothalamic control of bone metabolism, Best Pract. Res. Clin. Endocrinol. Metab., 28, 713, 10.1016\u002Fj.beem.2014.04.003\nKarsenty, 2006, Convergence between bone and energy homeostases: Leptin regulation of bone mass, Cell Metab., 4, 341, 10.1016\u002Fj.cmet.2006.10.008\nZhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038\u002F372425a0\nPradhan, 2013, Ghrelin: much more than a hunger hormone, Curr. Opin. Clin. Nutr. Metab. Care, 16, 619, 10.1097\u002FMCO.0b013e328365b9be\nSchubert, 2016, Gastric acid secretion, Curr. Opin. Gastroenterol., 32, 452, 10.1097\u002FMOG.0000000000000308\nPoher, 2018, Ghrelin regulation of glucose metabolism, Peptides, 100, 236, 10.1016\u002Fj.peptides.2017.12.015\nPerry, 2016, Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome, Nature, 534, 213, 10.1038\u002Fnature18309\nWeger, 2019, The mouse microbiome is required for sex-specific diurnal rhythms of gene expression and metabolism, Cell Metab., 29, 362, 10.1016\u002Fj.cmet.2018.09.023\nQueipo-Ortuno, 2013, Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels, PLoS One, 8, 10.1371\u002Fjournal.pone.0065465\nParnell, 2009, Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults, Am. J. Clin. Nutr., 89, 1751, 10.3945\u002Fajcn.2009.27465\nFukumori, 2011, Plasma ghrelin concentration is decreased by short chain fatty acids in wethers, Domest. Anim. Endocrinol., 41, 50, 10.1016\u002Fj.domaniend.2011.04.001\nRahat-Rozenbloom, 2017, The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans, Eur. J. Clin. Nutr., 71, 227, 10.1038\u002Fejcn.2016.248\nTorres-Fuentes, 2019, Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling, FASEB J., 33, 13546, 10.1096\u002Ffj.201901433R\nYue, 2016, Leptin receptor promotes Adipogenesis and reduces Osteogenesis by regulating mesenchymal stromal cells in adult bone marrow, Cell Stem Cell, 18, 782, 10.1016\u002Fj.stem.2016.02.015\nHe, 2016, The relationship between gene polymorphism of Leptin and Leptin receptor and growth hormone deficiency, Med. Sci. Monit., 22, 642, 10.12659\u002FMSM.894978\nSchorr, 2017, The endocrine manifestations of anorexia nervosa: mechanisms and management, Nat. Rev. Endocrinol., 13, 174, 10.1038\u002Fnrendo.2016.175\nLam, 2012, Intestinal microbiota determine severity of myocardial infarction in rats, FASEB J., 26, 1727, 10.1096\u002Ffj.11-197921\nRavussin, 2012, Responses of gut microbiota to diet composition and weight loss in lean and obese mice, Obesity (Silver Spring), 20, 738, 10.1038\u002Foby.2011.111\nKazemi, 2020, Effect of probiotic and prebiotic versus placebo on appetite in patients with major depressive disorder: post hoc analysis of a randomised clinical trial, J. Hum. Nutr. Diet., 33, 56, 10.1111\u002Fjhn.12675\nBagarolli, 2017, Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice, J. Nutr. Biochem., 50, 16, 10.1016\u002Fj.jnutbio.2017.08.006\nChoi, 2019, Antiobesity effects of Lactobacillus plantarum LMT1-48 accompanied by inhibition of Enterobacter cloacae in the intestine of diet-induced obese mice, J. Med. Food, 22, 560, 10.1089\u002Fjmf.2018.4329\nTakemura, 2010, Lactobacillus plantarum strain no. 14 reduces adipocyte size in mice fed high-fat diet, Exp. Biol. Med. (Maywood), 235, 849, 10.1258\u002Febm.2010.009377\nNaruszewicz, 2002, Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers, Am. J. Clin. Nutr., 76, 1249, 10.1093\u002Fajcn\u002F76.6.1249\nGabriel, 2019, The association of short-chain fatty acids and leptin metabolism: a systematic review, Nutr. Res., 72, 18, 10.1016\u002Fj.nutres.2019.08.006\nRajala, 2014, Leptin acts independently of food intake to modulate gut microbial composition in male mice, Endocrinology, 155, 748, 10.1210\u002Fen.2013-1085\nLucey, 1986, Endogenous somatostatin and the gut, Gut, 27, 457, 10.1136\u002Fgut.27.4.457\nSiler, 1974, Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor, J. Clin. Endocrinol. Metab., 38, 742, 10.1210\u002Fjcem-38-5-742\nKatznelson, 2014, Acromegaly: an endocrine society clinical practice guideline, J. Clin. Endocrinol. Metab., 99, 3933, 10.1210\u002Fjc.2014-2700\nBurroughs, 1993, Potential indications for octreotide in gastroenterology: summary of workshop, DIG, 54, 59, 10.1159\u002F000201079\nResmini, 2007, Evidence of prolonged Orocecal transit time and small intestinal bacterial overgrowth in Acromegalic patients, J. Clin. Endocrinol. Metab., 92, 2119, 10.1210\u002Fjc.2006-2509\nChowers, 2000, Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells, J. Immunol., 165, 2955, 10.4049\u002Fjimmunol.165.6.2955\nTerry, 2018, Lipid malabsorption from altered hormonal signaling changes early gut microbial responses, Am. J. Physiol. Gastrointest. Liver Physiol., 315, G580, 10.1152\u002Fajpgi.00135.2018\nYu, 2019, Effects of low-protein diet on the intestinal morphology, digestive enzyme activity, blood urea nitrogen, and gut microbiota and metabolites in weaned pigs, Arch. Anim. Nutr., 73, 287, 10.1080\u002F1745039X.2019.1614849\nLeRoith, 1985, Evidence for multiple molecular weight forms of somatostatin-like material in Escherichia coli, Biochim. Biophys. Acta, 838, 335, 10.1016\u002F0304-4165(85)90231-4\nLeRoith, 1985, Bacillus subtilis contains multiple forms of somatostatin-like material, Biochem. Biophys. Res. Commun., 127, 713, 10.1016\u002FS0006-291X(85)80001-2\nWang, 2015, Stability of peptide drugs in the colon, Eur. J. Pharm. Sci., 78, 31, 10.1016\u002Fj.ejps.2015.06.018\nCheng, 2019, Early intervention with faecal microbiota transplantation: an effective means to improve growth performance and the intestinal development of suckling piglets, Animal, 13, 533, 10.1017\u002FS1751731118001611\nLu, 2018, Effects of intestinal microbiota on brain development in humanized Gnotobiotic mice, Sci. Rep., 8\nStorelli, 2011, Lactobacillus plantarum promotes Drosophila systemic growth by modulating hormonal signals through TOR-dependent nutrient sensing, Cell Metab., 14, 403, 10.1016\u002Fj.cmet.2011.07.012\nShin, 2011, Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling, Science, 334, 670, 10.1126\u002Fscience.1212782\nSalehizadeh, 2019, Effects of probiotic lactic acid bacteria on growth performance, carcass characteristics, hematological indices, humoral immunity, and IGF-I gene expression in broiler chicken, Trop. Anim. Health Prod., 51, 2279, 10.1007\u002Fs11250-019-01935-w\nHumam, 2019, Effects of feeding different Postbiotics produced by Lactobacillus plantarum on growth performance, carcass yield, intestinal morphology, gut microbiota composition, immune status, and growth gene expression in broilers under heat stress, Animals (Basel), 9\nIzuddin, 2019, Effects of postbiotic supplementation on growth performance, ruminal fermentation and microbial profile, blood metabolite and GHR, IGF-1 and MCT-1 gene expression in post-weaning lambs, BMC Vet. Res., 15, 10.1186\u002Fs12917-019-2064-9\nWang, 2013, Short-chain fatty acids inhibit growth hormone and prolactin gene transcription via cAMP\u002FPKA\u002FCREB signaling pathway in dairy cow anterior pituitary cells, Int. J. Mol. Sci., 14, 21474, 10.3390\u002Fijms141121474\nHuang, 2019, Viral hormones: expanding dimensions in endocrinology, Endocrinology, 160, 2165, 10.1210\u002Fen.2019-00271\nAltindis, 2018, Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: a paradigm shift for host-microbe interactions, Proc. Natl. Acad. Sci. U. S. A., 115, 2461, 10.1073\u002Fpnas.1721117115\nBuford, 2018, Composition and richness of the serum microbiome differ by age and link to systemic inflammation, Geroscience, 40, 257, 10.1007\u002Fs11357-018-0026-y\nZheng, 2018, Intestinal epithelial cell-specific IGF1 promotes the expansion of intestinal stem cells during epithelial regeneration and functions on the intestinal immune homeostasis, Am. J. Physiol. Endocrinol. Metab., 315, E638, 10.1152\u002Fajpendo.00022.2018\nWiesenborn, 2020, The role of Ames dwarfism and calorie restriction on gut microbiota, J. Gerontol. A Biol. Sci. Med. Sci., 75, E1, 10.1093\u002Fgerona\u002Fglz236\nJensen, 2020, Growth hormone deficiency and excess alter the gut microbiome in adult male mice, Endocrinology, 161, 1, 10.1210\u002Fendocr\u002Fbqaa026\nChen, 2018, Distinct effects of growth hormone and glutamine on activation of intestinal stem cells, JPEN J. Parenter. Enteral Nutr., 42, 642, 10.1177\u002F0148607117709435\nKaymakci, 2014, Protective effects of growth hormone on bacterial translocation and intestinal damage in rats with partial intestinal obstruction, Bratisl. Lek. Listy, 115, 395\nBogazzi, 2009, Reduced colonic apoptosis in mice overexpressing bovine growth hormone occurs through changes in several kinase pathways, Growth Hormon. IGF Res., 19, 432, 10.1016\u002Fj.ghir.2009.01.002\nChesnokova, 2019, Growth hormone induces colon DNA damage independent of IGF-1, Endocrinology, 160, 1439, 10.1210\u002Fen.2019-00132\nChesnokova, 2016, Growth hormone is permissive for neoplastic colon growth, Proc. Natl. Acad. Sci. U. S. A., 113, E3250, 10.1073\u002Fpnas.1600561113\nLiu, 2020, Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment, Nat. Commun., 11\nTripathi, 2018, The gut-liver axis and the intersection with the microbiome, Nat. Rev. Gastroenterol. Hepatol., 15, 397, 10.1038\u002Fs41575-018-0011-z\nLundgren, 2020, The microbiome-adipose tissue axis in systemic metabolism, Am. J. Physiol. Gastrointest. Liver Physiol., 318, G717, 10.1152\u002Fajpgi.00304.2019\nXiao, 2020, The role of the gut microbiome in energy balance with a focus on the gut-adipose tissue Axis, Front. Genet., 11, 297, 10.3389\u002Ffgene.2020.00297\nTicinesi, 2019, Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis, Exerc. Immunol. Rev., 25, 84\nZhernakova, 2016, Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity, Science, 352, 565, 10.1126\u002Fscience.aad3369\nFalony, 2016, Population-level analysis of gut microbiome variation, Science, 352, 560, 10.1126\u002Fscience.aad3503\nGaulke, 2018, The influence of ethnicity and geography on human gut microbiome composition, Nat. Med., 24, 1495, 10.1038\u002Fs41591-018-0210-8\nHe, 2018, Regional variation limits applications of healthy gut microbiome reference ranges and disease models, Nat. Med., 24, 1532, 10.1038\u002Fs41591-018-0164-x\nMa, 2019, How and why men and women differ in their microbiomes: medical ecology and network analyses of the Microgenderome, Adv. Sci. (Weinh.), 6\nLeung, 2004, Estrogen regulation of growth hormone action, Endocr. Rev., 25, 693, 10.1210\u002Fer.2003-0035\nJessup, 2003, Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men, J. Clin. Endocrinol. Metab., 88, 4776, 10.1210\u002Fjc.2003-030246\nOuteirino-Blanco, 2012, Sexual dimorphism on growth hormone secretion after oral glucose administration, Horm. Metab. Res., 44, 533, 10.1055\u002Fs-0032-1304578\nKang, 2017, Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet, mBio, 8, 10.1128\u002FmBio.00470-17",{"EN":616},"Crosstalk between the growth hormone\u002Finsulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology",{"VOID":618},"10.1016\u002Fj.ghir.2020.101333","2025-02-02T23:41:49.646+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637420300423",[622,657,684,728,764,786,827,846,858,870],{"id":623,"sortIndex":283,"researcher":18,"roles":624,"affiliations":625,"properties":654},"3dca070b-7ed4-45ec-948c-d17e86e6649a",[133],[626,636,644],{"id":627,"sortIndex":238,"affiliation":628,"properties":635},"03da9960-4093-45a2-a254-57d6fc94fd5f",{"id":629,"createTime":630,"updateTime":630,"relativeEntities":631,"slug":18,"properties":632,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"42bf4eec-d5b8-4e25-9902-a059d620264b","2023-12-06T15:34:51.533+00:00",[],{"title":633},{"VI":634},"The Diabetes Institute, Parks Hall Suite 142, Ohio University, Athens, OH, United States of America",{},{"id":18,"sortIndex":19,"affiliation":637,"properties":18},{"id":638,"createTime":639,"updateTime":639,"relativeEntities":640,"slug":18,"properties":641,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c29067c1-4e2a-417e-85b0-6e52d9140a31","2023-12-06T15:34:51.580+00:00",[],{"title":642},{"VI":643},"Translational Biomedical Sciences Graduate Program, Graduate College, Ohio University, Athens, OH, United States of America",{"id":645,"sortIndex":104,"affiliation":646,"properties":653},"076e5a6b-fd01-4f05-86ab-e15d86265976",{"id":647,"createTime":648,"updateTime":648,"relativeEntities":649,"slug":18,"properties":650,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9727c747-16a0-4699-98af-5cb3c75e4a07","2023-12-06T15:34:51.464+00:00",[],{"title":651},{"VI":652},"Edison Biotechnology Institute, Konneker Research Labs, Athens, OH, United States of America",{},{"title":655},{"VI":656},"Edward O. List",{"id":658,"sortIndex":254,"researcher":18,"roles":659,"affiliations":660,"properties":681},"bf66ba38-bb9e-47bc-a7c7-de55c6d0cb77",[133],[661,671],{"id":18,"sortIndex":19,"affiliation":662,"properties":18},{"id":663,"createTime":664,"updateTime":665,"relativeEntities":666,"slug":667,"properties":668,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"00cd811f-02f6-4e98-9158-7217162691d1","2023-12-06T15:34:51.513+00:00","2025-06-11T14:17:33.805+00:00",[],"Department-of-Biological-Sciences-College-of-Arts-and-Sciences-Ohio-University-Athens-OH-United-States-of-America",{"title":669},{"VI":670},"Department of Biological Sciences, College of Arts and Sciences, Ohio University, Athens, OH, United States of America",{"id":672,"sortIndex":104,"affiliation":673,"properties":680},"8715d01d-2dfb-4fd7-93ef-1bcb5db3c9bb",{"id":674,"createTime":675,"updateTime":675,"relativeEntities":676,"slug":18,"properties":677,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9643f3b3-d643-4277-8cf1-bc28af6d6d21","2023-12-06T15:34:51.559+00:00",[],{"title":678},{"VI":679},"Molecular and Cellular Biology Program, Ohio University, Athens, OH, United States of America",{},{"title":682},{"VI":683},"Ronan K. Carroll",{"id":685,"sortIndex":686,"researcher":18,"roles":687,"affiliations":688,"properties":725},"3e895bfc-1e28-4b0e-aa0d-98adc53f1037",7,[133],[689,699,706,711,718],{"id":690,"sortIndex":254,"affiliation":691,"properties":698},"5504f51f-b27e-4e55-9606-4efe61dc7023",{"id":692,"createTime":693,"updateTime":693,"relativeEntities":694,"slug":18,"properties":695,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"ae84756d-3286-4fb1-9c98-7c9ab920d9dd","2023-12-06T15:34:51.563+00:00",[],{"title":696},{"VI":697},"Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States of America",{},{"id":700,"sortIndex":283,"affiliation":701,"properties":705},"b7fe60c3-3ecc-499f-8ddc-a79d831fba30",{"id":674,"createTime":675,"updateTime":675,"relativeEntities":702,"slug":18,"properties":703,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":704},{"VI":679},{},{"id":18,"sortIndex":19,"affiliation":707,"properties":18},{"id":638,"createTime":639,"updateTime":639,"relativeEntities":708,"slug":18,"properties":709,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":710},{"VI":643},{"id":712,"sortIndex":104,"affiliation":713,"properties":717},"6134ac86-057c-46d0-9271-c046a38c6d4a",{"id":647,"createTime":648,"updateTime":648,"relativeEntities":714,"slug":18,"properties":715,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":716},{"VI":652},{},{"id":719,"sortIndex":238,"affiliation":720,"properties":724},"ff5048f9-ae2e-4b7a-8f9c-94400f609019",{"id":629,"createTime":630,"updateTime":630,"relativeEntities":721,"slug":18,"properties":722,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":723},{"VI":634},{},{"title":726},{"VI":727},"John J. Kopchick",{"id":729,"sortIndex":59,"researcher":18,"roles":730,"affiliations":731,"properties":761},"ca6701f8-80f2-434d-85d4-8917fc5b1dac",[133],[732,737,744,751],{"id":18,"sortIndex":19,"affiliation":733,"properties":18},{"id":638,"createTime":639,"updateTime":639,"relativeEntities":734,"slug":18,"properties":735,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":736},{"VI":643},{"id":738,"sortIndex":238,"affiliation":739,"properties":743},"63ddfef7-4575-45cd-8b7c-2c8d3dcaeacf",{"id":692,"createTime":693,"updateTime":693,"relativeEntities":740,"slug":18,"properties":741,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":742},{"VI":697},{},{"id":745,"sortIndex":104,"affiliation":746,"properties":750},"1843c833-612a-4ee8-9ceb-5906c25593d4",{"id":674,"createTime":675,"updateTime":675,"relativeEntities":747,"slug":18,"properties":748,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":749},{"VI":679},{},{"id":752,"sortIndex":283,"affiliation":753,"properties":760},"87d7e1ed-05fd-494c-aba3-a1f1b951b542",{"id":754,"createTime":755,"updateTime":755,"relativeEntities":756,"slug":18,"properties":757,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"127a4139-f3dc-4621-94d0-15e6716e41be","2023-12-06T15:34:51.567+00:00",[],{"title":758},{"VI":759},"Infectious and Tropical Diseases Institute, Irvine Hall, Ohio University, Athens, OH, United States of America",{},{"title":762},{"VI":763},"Erin R. Murphy",{"id":765,"sortIndex":19,"researcher":18,"roles":766,"affiliations":767,"properties":783},"6fabd510-6c93-4b82-9755-965f47b34c2d",[133],[768,773],{"id":18,"sortIndex":19,"affiliation":769,"properties":18},{"id":638,"createTime":639,"updateTime":639,"relativeEntities":770,"slug":18,"properties":771,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":772},{"VI":643},{"id":774,"sortIndex":104,"affiliation":775,"properties":782},"dbb17814-7f07-4fa8-b0ec-8d0c0d59135a",{"id":776,"createTime":777,"updateTime":777,"relativeEntities":778,"slug":18,"properties":779,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"827d26c1-d86a-47f6-ad7b-3008028fa531","2023-12-06T15:34:51.420+00:00",[],{"title":780},{"VI":781},"Ohio University Heritage College of Osteopathic Medicine, Athens, OH, United States of America",{},{"title":784},{"VI":785},"Elizabeth A. Jensen",{"id":787,"sortIndex":788,"researcher":18,"roles":789,"affiliations":790,"properties":824},"3468327c-6562-49ff-9250-5a66dd2165ee",9,[133],[791,798,805,812,819],{"id":792,"sortIndex":254,"affiliation":793,"properties":797},"fe704c75-fbe0-4b2c-b03a-9ca3170eb5d7",{"id":692,"createTime":693,"updateTime":693,"relativeEntities":794,"slug":18,"properties":795,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":796},{"VI":697},{},{"id":799,"sortIndex":283,"affiliation":800,"properties":804},"0a4d5d88-946a-49b9-87e2-6c4becb49a44",{"id":674,"createTime":675,"updateTime":675,"relativeEntities":801,"slug":18,"properties":802,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":803},{"VI":679},{},{"id":806,"sortIndex":238,"affiliation":807,"properties":811},"f5171871-3f3f-4ec6-89c2-4a25450a5148",{"id":629,"createTime":630,"updateTime":630,"relativeEntities":808,"slug":18,"properties":809,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":810},{"VI":634},{},{"id":813,"sortIndex":104,"affiliation":814,"properties":818},"4057b1d4-a069-4bad-b81a-2743e6caef91",{"id":647,"createTime":648,"updateTime":648,"relativeEntities":815,"slug":18,"properties":816,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":817},{"VI":652},{},{"id":18,"sortIndex":19,"affiliation":820,"properties":18},{"id":638,"createTime":639,"updateTime":639,"relativeEntities":821,"slug":18,"properties":822,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":823},{"VI":643},{"title":825},{"VI":826},"Darlene E. Berryman",{"id":828,"sortIndex":104,"researcher":18,"roles":829,"affiliations":830,"properties":843},"873fdfb2-bd18-4364-9f83-19807b13ff3d",[133],[831,836],{"id":18,"sortIndex":19,"affiliation":832,"properties":18},{"id":776,"createTime":777,"updateTime":777,"relativeEntities":833,"slug":18,"properties":834,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":835},{"VI":781},{"id":837,"sortIndex":104,"affiliation":838,"properties":842},"dbac6b0f-be69-48fd-9e1f-4b3ea8f49166",{"id":647,"createTime":648,"updateTime":648,"relativeEntities":839,"slug":18,"properties":840,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":841},{"VI":652},{},{"title":844},{"VI":845},"Jonathan A. Young",{"id":847,"sortIndex":210,"researcher":18,"roles":848,"affiliations":849,"properties":855},"9502f09f-1f0f-4145-ac18-3dcc186c3b9a",[133],[850],{"id":18,"sortIndex":19,"affiliation":851,"properties":18},{"id":647,"createTime":648,"updateTime":648,"relativeEntities":852,"slug":18,"properties":853,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":854},{"VI":652},{"title":856},{"VI":857},"Jaycie Kuhn",{"id":859,"sortIndex":238,"researcher":18,"roles":860,"affiliations":861,"properties":867},"5dec05aa-a032-44b7-9b8a-812e0da7bea7",[133],[862],{"id":18,"sortIndex":19,"affiliation":863,"properties":18},{"id":647,"createTime":648,"updateTime":648,"relativeEntities":864,"slug":18,"properties":865,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":866},{"VI":652},{"title":868},{"VI":869},"Samuel C. Mathes",{"id":871,"sortIndex":270,"researcher":18,"roles":872,"affiliations":873,"properties":886},"4f68bb97-bdc0-479e-9fa4-70cdc48fec2b",[133],[874,879],{"id":18,"sortIndex":19,"affiliation":875,"properties":18},{"id":629,"createTime":630,"updateTime":630,"relativeEntities":876,"slug":18,"properties":877,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":878},{"VI":634},{"id":880,"sortIndex":104,"affiliation":881,"properties":885},"879ff1b5-fb6d-433b-b627-ad5de2a06436",{"id":663,"createTime":664,"updateTime":665,"relativeEntities":882,"slug":667,"properties":883,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":884},{"VI":670},{},{"title":887},{"VI":888},"Maria Onusko",{"url":620,"publisher":890,"properties":917},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":891,"slug":10,"properties":892,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":895,"manageAffiliations":896,"indexDatabases":897,"url":18,"thumbnailPath":18,"statistic":912,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":893,"title":894},{"VOID":13},{"EN":15},[],[],[898,905],{"id":83,"indexDatabase":899,"url":96,"indexYears":97,"academicFieldIds":904,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":900,"label":901,"description":902,"key":93,"publicationTags":903,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":906,"url":78,"indexYears":18,"academicFieldIds":911,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":907,"label":908,"description":909,"key":74,"publicationTags":910,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":913,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":914,"totalCitation":19,"totalCitationByYear":915,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":916,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":918,"pages":920},{"VOID":919},"53",{"VOID":921},"101333","2020-08-01",2020,{"id":925,"createTime":926,"updateTime":927,"relativeEntities":928,"slug":929,"properties":930,"entityType":125,"verifyStatus":126,"verifyTime":927,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":937,"fullTextUrl":18,"authors":938,"publicationType":158,"publisherRelationship":978,"citationCount":18,"citationInfo":18,"publishDate":1011,"publishYear":1012,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"2538bcf4-3314-4900-8780-9be13358c485","2023-12-06T23:16:14.749+00:00","2024-12-12T23:41:25.294+00:00",[],"Visceral-obesity-and-the-role-of-the-somatotropic-axis-in-the-development-of-metabolic-complications",{"references":931,"title":933,"doi":935},{"VOID":932},"Johansson, 1994, High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults, Arterioscler Thromb, 14, 434, 10.1161\u002F01.ATV.14.3.434\nRosmond, 2000, The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke, J Intern Med, 247, 188, 10.1046\u002Fj.1365-2796.2000.00603.x\nBoyko, 2000, Visceral adiposity and risk of type 2 diabetes a prospective study among Japanese Americans, Diabetes Care, 23, 465, 10.2337\u002Fdiacare.23.4.465\nBjörntorp, 1993, Visceral obesity: a civilisation syndrome, Obes Res, 1, 206, 10.1002\u002Fj.1550-8528.1993.tb00614.x\nBouchard, 1990, Basic and clinical aspects of regional fat distribution, Am J Clin Nutr, 52, 946, 10.1093\u002Fajcn\u002F52.5.946\nBjörntorp, 1996, Diabetes, 68\nCox, 1998, The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults, Int J Obes Relat Metab Disord, 22, 966, 10.1038\u002Fsj.ijo.0800705\nRosmond, 1998, Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men, J Hypertens, 16, 1721, 10.1097\u002F00004872-199816120-00003\nPouliot, 1994, Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation andrelated cardiovascular risk in men and women, Am J Cardiol, 73, 460, 10.1016\u002F0002-9149(94)90676-9\nLean, 1995, Waist circumference as a measure for indicating need for weight management, BMJ, 311, 158, 10.1136\u002Fbmj.311.6998.158\nRexrode, 1998, Abdominal adiposity and coronary heart disease in women, JAMA, 280, 1843, 10.1001\u002Fjama.280.21.1843\nÖhrvall, 2000, Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk, Int J Obes Relat Metab Disord, 24, 497, 10.1038\u002Fsj.ijo.0801186\n1999\nBrummer, 1998, Effects of growth hormone treatment on visceral adipose tissue, Growth Horm IGF Res, 8, 19, 10.1016\u002FS1096-6374(98)80021-X\nHan, 1997, Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnet resonance imaging, Int J Obes Relat Metab Disord, 21, 1161, 10.1038\u002Fsj.ijo.0800530\nAbate, 1996, Insulin resistance and obesity, the role of fat distribution pattern, Diabetes Care, 19, 292, 10.2337\u002Fdiacare.19.3.292\nKissebah, 1982, Relation of body fat distribution to metabolic complications of obesity, J Clin Endocrinol Metab, 54, 254, 10.1210\u002Fjcem-54-2-254\nKissebah, 1994, Regional adiposity and morbidity, Physiol Rev, 74, 761, 10.1152\u002Fphysrev.1994.74.4.761\nScheen, 2000, From obesity to diabetes: why, when and who?, Acta Clin Belg, 55, 9, 10.1080\u002F17843286.2000.11754266\nRandle, 1963, The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbancies of diabetes mellitus, Lancet, I, 785, 10.1016\u002FS0140-6736(63)91500-9\nSheehan, 2000, Metabolic complications of obesity. Pathophysiologic considerations, Med Clin North Am, 84, 363, 10.1016\u002FS0025-7125(05)70226-1\nSteppan, 2001, The hormone resistin links obesity to diabetes, Nature, 409, 307, 10.1038\u002F35053000\nBjörntorp, 1995, Neuroendocrine abnormalities in human obesity, Metabolism, 44, 38, 10.1016\u002F0026-0495(95)90208-2\nWalker, 2001, Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?, Growth Horm IGF Res, 11, 91, 10.1016\u002FS1096-6374(01)80015-0\nMårin, 1998, Androgens and abdominal obesity, Baillières Clin Endocrinol Metab, 12, 441, 10.1016\u002FS0950-351X(98)80191-2\nBjörntorp, 1999, Perturbations of the hypothalamic-pituitary-adrenal axis and the metabolic syndrome in ageing, Growth Horm IGF Res, 9, 121, 10.1016\u002FS1096-6374(99)80024-0\nBjörntorp, 2000, Hypertension and the metabolic syndrome: closely related central origin?, Blood Press, 9, 71, 10.1080\u002F08037050050151762\nMårin, 1993, Androgen treatment of abdominally obese men, Obes Res, 1, 245, 10.1002\u002Fj.1550-8528.1993.tb00618.x\nLobo, 2000, The importance of diagnosing the polycystic ovary syndrome, Ann Intern Med, 132, 989, 10.7326\u002F0003-4819-132-12-200006200-00010\nIranmanesh, 1998, Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF binding protein responses toa three-day intravenous growth hormone-releasing hormone pulsatile infusion in men, Eur J Endocrinol, 139, 59, 10.1530\u002Feje.0.1390059\nJohannsson, 1999, Is GH therapy indicated in the metabolic syndrome?, 264\nVeldhuis, 1996, Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity,gonadal function, and sleep, Sleep, 19, S221, 10.1093\u002Fsleep\u002F19.suppl_10.S221\nVeldhuis, 2001, Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human, Growth Horm IGF Res, 11, 25, 10.1016\u002FS1096-6374(01)80005-8\nJohannsson G, Mårin P, Johansson J-O, Bengtsson B-Å. Growthhormone and syndrome X. In: Smith RG, Thorner MO (eds.). Human growth hormone: research and clinical practice. Totowa, NJ: Humana Press: 247–260.\nMårin, 1993, Low concentrations of insulin-like growth factor- in abdominal obesity, Int J Obes Relat Metab Disord, 17, 83\nNam, 1999, GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis, Eur J Endocrinol, 140, 159, 10.1530\u002Feje.0.1400159\nJohannsson, 1999, Growth hormone and the metabolic syndrome, J Endocrinol Invest, 22, 41\nJohannsson, 2000, Growth hormone and ageing, Growth Horm IGF Res, 10, S25, 10.1016\u002FS1096-6374(00)80006-4\nBengtsson, 1993, Treatment of adults with growth hormone (GH) deficiency with recombinant human GH, J Clin Endocrinol Metab, 76, 309, 10.1210\u002Fjc.76.2.309\nJohannsson, 1997, Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure, J Clin Endocrinol Metab, 82, 727, 10.1210\u002Fjc.82.3.727\nHoward, 1996, A receptor in pituitary and hypothalamus that functions in growth hormone release, Science, 273, 974, 10.1126\u002Fscience.273.5277.974\nGuillaume, 1994, Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep, Endocrinology, 135, 1073, 10.1210\u002Fen.135.3.1073\nLieber, 1997, Growth hormone secretagogues increases muscle strength during remobilization after canine hindlimb immobilization, J Orthop Res, 15, 519, 10.1002\u002Fjor.1100150407\nLaron, 1995, Intranasal administration of the GHRP hexarelin accelerates growth in short children, Clin Endocrinol (Oxf), 43, 631, 10.1111\u002Fj.1365-2265.1995.tb02929.x\nSvensson, 1998, Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energyexpenditure, J Clin Endocrinol Metab, 83, 362, 10.1210\u002Fjc.83.2.362\nJames, 1996, The epidemiology of obesity, 1\nNarbro, 1999, Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study, Int J Obes Relat Metab Disord, 23, 619, 10.1038\u002Fsj.ijo.0800890",{"EN":934},"Visceral obesity and the role of the somatotropic axis in the development of metabolic complications",{"VOID":936},"10.1016\u002Fs1096-6374(01)80016-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637401800162",[939,954,966],{"id":940,"sortIndex":19,"researcher":18,"roles":941,"affiliations":942,"properties":951},"ea53e685-605e-49b8-80db-4f7cd64d4d37",[133],[943],{"id":18,"sortIndex":19,"affiliation":944,"properties":18},{"id":945,"createTime":946,"updateTime":946,"relativeEntities":947,"slug":18,"properties":948,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c668be32-0466-4f22-bfeb-b52894fa8aaa","2023-12-06T23:16:14.839+00:00",[],{"title":949},{"VI":950},"Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden",{"title":952},{"VI":953},"Celina Franco",{"id":955,"sortIndex":238,"researcher":18,"roles":956,"affiliations":957,"properties":963},"e97305a4-2b54-4848-9f9a-6f08553fdea0",[133],[958],{"id":18,"sortIndex":19,"affiliation":959,"properties":18},{"id":945,"createTime":946,"updateTime":946,"relativeEntities":960,"slug":18,"properties":961,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":962},{"VI":950},{"title":964},{"VI":965},"Gudmundur Johannsson",{"id":967,"sortIndex":104,"researcher":18,"roles":968,"affiliations":969,"properties":975},"38e1c9e9-9404-4b2f-862e-9c5529f60507",[133],[970],{"id":18,"sortIndex":19,"affiliation":971,"properties":18},{"id":945,"createTime":946,"updateTime":946,"relativeEntities":972,"slug":18,"properties":973,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":974},{"VI":950},{"title":976},{"VI":977},"Bengt-Åke Bengtsson",{"url":937,"publisher":979,"properties":1006},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":980,"slug":10,"properties":981,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":984,"manageAffiliations":985,"indexDatabases":986,"url":18,"thumbnailPath":18,"statistic":1001,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":982,"title":983},{"VOID":13},{"EN":15},[],[],[987,994],{"id":83,"indexDatabase":988,"url":96,"indexYears":97,"academicFieldIds":993,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":989,"label":990,"description":991,"key":93,"publicationTags":992,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":995,"url":78,"indexYears":18,"academicFieldIds":1000,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":996,"label":997,"description":998,"key":74,"publicationTags":999,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":1002,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":1003,"totalCitation":19,"totalCitationByYear":1004,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":1005,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":1007,"pages":1009},{"VOID":1008},"11",{"VOID":1010},"S97-S102","2001-06-01",2001,{"id":1014,"createTime":1015,"updateTime":1016,"relativeEntities":1017,"slug":1018,"properties":1019,"entityType":125,"verifyStatus":126,"verifyTime":1016,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1024,"fullTextUrl":18,"authors":1025,"publicationType":158,"publisherRelationship":1104,"citationCount":18,"citationInfo":18,"publishDate":1137,"publishYear":1138,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"49b01470-28aa-4470-b2ea-883f26722c57","2024-01-05T02:03:33.287+00:00","2025-02-22T23:41:06.142+00:00",[],"Increased-not-decreased-activation-of-the-insulin-like-growth-factor-IGF-receptor-signalling-pathway-during-ceramide-induced-apoptosis",{"title":1020,"doi":1022},{"EN":1021},"Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis",{"VOID":1023},"10.1054\u002Fghir.1999.0098","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637499900989",[1026,1041,1053,1068,1080,1092],{"id":1027,"sortIndex":254,"researcher":18,"roles":1028,"affiliations":1029,"properties":1038},"edd5b309-051c-438d-ae19-1efc694dd278",[133],[1030],{"id":18,"sortIndex":19,"affiliation":1031,"properties":18},{"id":1032,"createTime":1033,"updateTime":1033,"relativeEntities":1034,"slug":18,"properties":1035,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"50985eb1-c9c0-4aa5-8427-9d0127f2dc11","2024-01-05T02:03:33.341+00:00",[],{"title":1036},{"VI":1037},"University Dept of Biochemistry, Bristol Royal Infirmary, Bristol, BS2 8HW, UK",{"title":1039},{"VI":1040},"J. Tavare",{"id":1042,"sortIndex":283,"researcher":18,"roles":1043,"affiliations":1044,"properties":1050},"1ac0a2ea-406d-4cc7-957a-58dd5f1c2cef",[133],[1045],{"id":18,"sortIndex":19,"affiliation":1046,"properties":18},{"id":1032,"createTime":1033,"updateTime":1033,"relativeEntities":1047,"slug":18,"properties":1048,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1049},{"VI":1037},{"title":1051},{"VI":1052},"M. Dickens",{"id":1054,"sortIndex":210,"researcher":18,"roles":1055,"affiliations":1056,"properties":1065},"3096e88b-41cc-4e12-8892-0da19e1b34e9",[133],[1057],{"id":18,"sortIndex":19,"affiliation":1058,"properties":18},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1061,"slug":18,"properties":1062,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"54a1bca3-a6a6-41e6-aa2e-eb7e131088aa","2024-01-05T02:03:33.300+00:00",[],{"title":1063},{"VI":1064},"University Dept of Surgery, Bristol Royal Infirmary, Bristol, BS2 8HW, UK",{"title":1066},{"VI":1067},"J.M.P. Holly",{"id":1069,"sortIndex":19,"researcher":18,"roles":1070,"affiliations":1071,"properties":1077},"f36d7e67-59a2-49d4-b43f-f544511aa6db",[133],[1072],{"id":18,"sortIndex":19,"affiliation":1073,"properties":18},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1074,"slug":18,"properties":1075,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1076},{"VI":1064},{"title":1078},{"VI":1079},"C.E.H. Stewart",{"id":1081,"sortIndex":238,"researcher":18,"roles":1082,"affiliations":1083,"properties":1089},"cc6f60a0-cbcc-4907-8de2-d5247337c39b",[133],[1084],{"id":18,"sortIndex":19,"affiliation":1085,"properties":18},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1086,"slug":18,"properties":1087,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1088},{"VI":1064},{"title":1090},{"VI":1091},"P.B. Savage",{"id":1093,"sortIndex":104,"researcher":18,"roles":1094,"affiliations":1095,"properties":1101},"f98c898a-2ae0-452e-98c1-256f39af4d67",[133],[1096],{"id":18,"sortIndex":19,"affiliation":1097,"properties":18},{"id":1059,"createTime":1060,"updateTime":1060,"relativeEntities":1098,"slug":18,"properties":1099,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1100},{"VI":1064},{"title":1102},{"VI":1103},"P.V. Newcomb",{"url":1024,"publisher":1105,"properties":1132},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1106,"slug":10,"properties":1107,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1110,"manageAffiliations":1111,"indexDatabases":1112,"url":18,"thumbnailPath":18,"statistic":1127,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1108,"title":1109},{"VOID":13},{"EN":15},[],[],[1113,1120],{"id":83,"indexDatabase":1114,"url":96,"indexYears":97,"academicFieldIds":1119,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":1115,"label":1116,"description":1117,"key":93,"publicationTags":1118,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":1121,"url":78,"indexYears":18,"academicFieldIds":1126,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":1122,"label":1123,"description":1124,"key":74,"publicationTags":1125,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":1128,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":1129,"totalCitation":19,"totalCitationByYear":1130,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":1131,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":1133,"pages":1135},{"VOID":1134},"9",{"VOID":1136},"131-142","1999-05-01",1999,{"id":1140,"createTime":1141,"updateTime":1142,"relativeEntities":1143,"slug":1144,"properties":1145,"entityType":125,"verifyStatus":126,"verifyTime":1152,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1153,"fullTextUrl":18,"authors":1154,"publicationType":158,"publisherRelationship":1233,"citationCount":18,"citationInfo":18,"publishDate":1266,"publishYear":1267,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"df6e23ab-c55b-4580-9e07-b4032af7686a","2024-01-17T20:08:35.097+00:00","2025-01-18T23:38:48.068+00:00",[],"Management-and-interpretation-of-heterogeneous-observational-data-Using-insulin-like-growth-factor-I-data-from-the-NordiNet-International-Outcome-Study",{"references":1146,"title":1148,"doi":1150},{"VOID":1147},"Burns, 2009, The First International Standard for Insulin-like Growth Factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study, Growth Horm. IGF. Res., 19, 457, 10.1016\u002Fj.ghir.2009.02.002\nBrabant, 2003, Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study, Horm. Res., 60, 53\nKrebs, 2008, Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population, Clin. Chem. Lab. Med., 46, 1776, 10.1515\u002FCCLM.2008.349\nBrugts, 2008, Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays, J. Clin. Endocrinol. Metab., 93, 2539, 10.1210\u002Fjc.2007-2454\nClemmons, 2011, Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays, Clin. Chem., 57, 555, 10.1373\u002Fclinchem.2010.150631\nBidlingmaier, 2009, Pitfalls of insulin-like growth factor I assays, Horm. Res., 71, 30\nFriedrich, 2008, Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP), Growth Horm. IGF. Res., 18, 228, 10.1016\u002Fj.ghir.2007.09.005\nElmlinger, 2004, Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3), Clin. Chem. Lab. Med., 42, 654, 10.1515\u002FCCLM.2004.112\nBidlingmaier, 2011, A new automated chemiluminescence immunoassay system to measure insulin-like growth factor I (IGF-I): validation and establishment of reference values [abstract], Endocr. Rev., 32, 1\nHoybye, 2013, Clin. Epidemiol., 5, 119, 10.2147\u002FCLEP.S42602\nLee, 2012, Int. J. Pediatr. Endocrinol., 2012, 22, 10.1186\u002F1687-9856-2012-22\nSavendahl, 2012, Gender influences short-term growth hormone treatment response in children, Horm. Res. Paediatr., 77, 188, 10.1159\u002F000337570\nMcLean, 1991, A unified approach to mixed linear models, Am. Stat., 45, 54\nBidlingmaier, 2014, Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations, J. Clin. Endocrinol. Metab., 99, 1712, 10.1210\u002Fjc.2013-3059\nJuul, 1994, Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index, J. Clin. Endocrinol. Metab., 78, 744\nFrystyk, 2010, The current status of IGF-I assays—a 2009 update, Growth Horm. IGF. Res., 20, 8, 10.1016\u002Fj.ghir.2009.09.004",{"EN":1149},"Management and interpretation of heterogeneous observational data: Using insulin-like growth factor-I data from the NordiNet® International Outcome Study",{"VOID":1151},"10.1016\u002Fj.ghir.2014.12.001","2025-01-18T23:38:48.067+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637414001166",[1155,1172,1188,1203,1218],{"id":1156,"sortIndex":254,"researcher":18,"roles":1157,"affiliations":1158,"properties":1169},"f758bd3d-c691-499d-ad0c-b254ae0723bb",[133],[1159],{"id":18,"sortIndex":19,"affiliation":1160,"properties":18},{"id":1161,"createTime":1162,"updateTime":1163,"relativeEntities":1164,"slug":1165,"properties":1166,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"24154c87-c84b-430e-819f-3760d0438a95","2023-12-12T14:56:44.988+00:00","2024-12-17T12:21:33.994+00:00",[],"Department-of-Clinical-Science-University-of-Bergen-Bergen-Norway",{"title":1167},{"VI":1168},"Department of Clinical Science, University of Bergen, Bergen, Norway",{"title":1170},{"VI":1171},"Pétur Benedikt Júlíusson",{"id":1173,"sortIndex":19,"researcher":18,"roles":1174,"affiliations":1175,"properties":1185},"62786590-8b53-47b0-8163-5e53d4ea52ab",[133],[1176],{"id":18,"sortIndex":19,"affiliation":1177,"properties":18},{"id":1178,"createTime":1179,"updateTime":1179,"relativeEntities":1180,"slug":1181,"properties":1182,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"d4d425d2-13d0-41c1-a7e1-1040e1d19782","2024-04-12T03:36:22.599+00:00",[],"Institute-for-Experimental-Paediatric-Endocrinology-Charit%C3%A9-Universit%C3%A4tsmedizin-Berlin-Berlin-Germany",{"title":1183},{"EN":1184},"Institute for Experimental Paediatric Endocrinology, Charité-Universitätsmedizin Berlin, Berlin, Germany",{"title":1186},{"VI":1187},"Oliver Blankenstein",{"id":1189,"sortIndex":104,"researcher":18,"roles":1190,"affiliations":1191,"properties":1200},"5025f12c-f66e-498b-a411-869b0fc68d1a",[133],[1192],{"id":18,"sortIndex":19,"affiliation":1193,"properties":18},{"id":1194,"createTime":1195,"updateTime":1195,"relativeEntities":1196,"slug":18,"properties":1197,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"dfaf4049-8ae7-4e89-b151-673b0094c630","2024-01-17T20:08:35.126+00:00",[],{"title":1198},{"VI":1199},"Epidemiology, Novo Nordisk A\u002FS, Søborg, Denmark",{"title":1201},{"VI":1202},"Birgitte Tønnes Pedersen",{"id":1204,"sortIndex":283,"researcher":18,"roles":1205,"affiliations":1206,"properties":1215},"fb58371f-23ad-4975-afa9-e1859143c040",[133],[1207],{"id":18,"sortIndex":19,"affiliation":1208,"properties":18},{"id":1209,"createTime":1210,"updateTime":1210,"relativeEntities":1211,"slug":18,"properties":1212,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"e713ef9f-554c-495f-b378-b206bedc25c5","2024-01-17T20:08:35.150+00:00",[],{"title":1213},{"VI":1214},"StatGroup ApS, Copenhagen, Denmark",{"title":1216},{"VI":1217},"Arne Haahr Andreasen",{"id":1219,"sortIndex":238,"researcher":18,"roles":1220,"affiliations":1221,"properties":1230},"32c7f498-edca-4d72-a731-e72fb00bbad2",[133],[1222],{"id":18,"sortIndex":19,"affiliation":1223,"properties":18},{"id":1224,"createTime":1225,"updateTime":1225,"relativeEntities":1226,"slug":18,"properties":1227,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"32bbdb28-4df8-4192-a111-1f97a19c719d","2024-01-17T20:08:35.137+00:00",[],{"title":1228},{"VI":1229},"Global Medical Affairs Biopharm, Novo Nordisk Health Care AG, Zurich, Switzerland",{"title":1231},{"VI":1232},"Michael Schlumpf",{"url":1153,"publisher":1234,"properties":1261},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1235,"slug":10,"properties":1236,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1239,"manageAffiliations":1240,"indexDatabases":1241,"url":18,"thumbnailPath":18,"statistic":1256,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1237,"title":1238},{"VOID":13},{"EN":15},[],[],[1242,1249],{"id":83,"indexDatabase":1243,"url":96,"indexYears":97,"academicFieldIds":1248,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":1244,"label":1245,"description":1246,"key":93,"publicationTags":1247,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":1250,"url":78,"indexYears":18,"academicFieldIds":1255,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":1251,"label":1252,"description":1253,"key":74,"publicationTags":1254,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":1257,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":1258,"totalCitation":19,"totalCitationByYear":1259,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":1260,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":1262,"pages":1264},{"VOID":1263},"25",{"VOID":1265},"41-46","2015-02-01",2015,{"id":1269,"createTime":1270,"updateTime":1271,"relativeEntities":1272,"slug":1273,"properties":1274,"entityType":125,"verifyStatus":126,"verifyTime":1271,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1281,"fullTextUrl":18,"authors":1282,"publicationType":158,"publisherRelationship":1310,"citationCount":18,"citationInfo":18,"publishDate":1343,"publishYear":1344,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"0cc07e57-9c7f-4d43-ad77-c4bcb8b84635","2023-12-13T03:11:39.046+00:00","2025-02-13T23:36:49.285+00:00",[],"Investigation-of-cardiac-status-and-bone-mineral-density-in-Turner-syndrome",{"references":1275,"title":1277,"doi":1279},{"VOID":1276},"Nielsen, 1990, Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark, Birth Defects Orig. Artic. Ser., 26, 209\nNielsen, 1991, Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark, Hum. Genet., 87, 81, 10.1007\u002FBF01213097\nGravholt, 1996, Prenatal and postnatal prevalence of Turner’s syndrome: a registry study, Br. Med. J., 312, 16, 10.1136\u002Fbmj.312.7022.16\nJacobs, 1974, A cytogenetic survey of 11,680 newborn infants, Ann. Hum. Genet., 37, 359, 10.1111\u002Fj.1469-1809.1974.tb01843.x\nLippe, 1991, Turner syndrome, Endocrinol. Metab. Clin. North Am., 20, 121, 10.1016\u002FS0889-8529(18)30284-6\nSybert, 2004, Turner’s syndrome, N. Engl. J. Med., 351, 1227, 10.1056\u002FNEJMra030360\nNijhuis-van der Sanden, 2003, A review of neuropsychological and motor studies in Turner syndrome, Neurosci. Biobehav. Rev., 27, 329, 10.1016\u002FS0149-7634(03)00062-9\nRoss, 2000, Neurodevelopmental and psychosocial aspects of Turner syndrome, Ment. Retard. Dev. Disabil. Res. Rev., 6, 135, 10.1002\u002F1098-2779(2000)6:2\u003C135::AID-MRDD8>3.0.CO;2-K\nSaenger, 2001, Recommendations for the diagnosis and management of Turner syndrome, J. Clin. Endocrinol. Metab., 86, 3061, 10.1210\u002Fjc.86.7.3061\nDawson-Falk, 1992, Cardiovascular evaluation in Turner syndrome: utility of MR imaging, Australas. Radiol., 36, 204, 10.1111\u002Fj.1440-1673.1992.tb03152.x\nHo, 2004, Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features, Circulation, 110, 1694, 10.1161\u002F01.CIR.0000142290.35842.B0\nBechtold, 2004, Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome, Eur. J. Pediatr., 163, 158, 10.1007\u002Fs00431-003-1384-7\nOstberg, 2004, A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome, J. Clin. Endocrinol. Metab., 89, 5966, 10.1210\u002Fjc.2004-1090\nPrandstraller, 1999, Turner’s syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients, Pediatr. Cardiol., 20, 108, 10.1007\u002Fs002469900416\nSybert, 1998, Cardiovascular malformations and complications in Turner syndrome, Pediatrics, 101, e11, 10.1542\u002Fpeds.101.1.e11\nPrice, 1986, Mortality ratios, life expectancy, and causes of death in patients with Turner’s syndrome, J. Epidemiol. Commun. Health, 40, 97, 10.1136\u002Fjech.40.2.97\nLin, 1998, Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome, Pediatrics, 102, e12, 10.1542\u002Fpeds.102.1.e12\nElsheikh, 2001, Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome, Clin. Endocrinol. (Oxf.), 54, 69, 10.1046\u002Fj.1365-2265.2001.01154.x\nBondy, 2006, Prolongation of the QTc interval in Turner syndrome, Medicine, 85, 1, 10.1097\u002F01.md.0000205629.16302.bc\nRobbins, 2003, The association between the length of the QT interval and mortality in the Cardiovascular Health Study, Am. J. Med., 115, 689, 10.1016\u002Fj.amjmed.2003.07.014\nMontanez, 2004, Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies, Arch. Intern. Med., 164, 943, 10.1001\u002Farchinte.164.9.943\nBlair, 2004, Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology, J. Neural Transm., 111, 791, 10.1007\u002Fs00702-004-0153-8\nBakalov, 2003, Bone mineral density and fractures in Turner syndrome, Am. J. Med., 115, 257, 10.1016\u002FS0002-9343(03)00364-4\nJobe, 2004, Deep venous thrombosis and Turner syndrome, J. Pediatr. Hematol. Oncol., 26, 272, 10.1097\u002F00043426-200404000-00014\nHanton, 2003, The importance of estrogen replacement in young women with Turner syndrome, J. Womens Health (Larchmt.), 12, 971, 10.1089\u002F154099903322643893\nGravholt, 2002, Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study, J. Clin. Endocrinol. Metab., 87, 2798, 10.1210\u002Fjc.87.6.2798\nBechtold, 2001, Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography, J. Clin. Endocrinol. Metab., 86, 5819, 10.1210\u002Fjc.86.12.5819\nDalla Palma, 1966, Turner’s syndrome: radiological appearances, Radiol. Clin. Biol., 35, 65\nHogler, 2004, Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry, J. Clin. Endocrinol. Metab., 89, 193, 10.1210\u002Fjc.2003-030799\nRao, 1997, Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome, Nat. Genet., 16, 54, 10.1038\u002Fng0597-54\nOgata, 1999, SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis, Growth Horm. IGF Res., 9, 53, 10.1016\u002FS1096-6374(99)80082-3\nRoss, 2001, Phenotypes associated with SHOX deficiency, J. Clin. Endocrinol. Metab., 86, 5674, 10.1210\u002Fjc.86.12.5674\nGravholt, 2003, Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey, Clin. Endocrinol. (Oxf.), 59, 89, 10.1046\u002Fj.1365-2265.2003.01807.x\nCosman, 2005, Daily and cyclic parathyroid hormone in women receiving alendronate, N. Engl. J. Med., 353, 566, 10.1056\u002FNEJMoa050157\nSas, 2001, Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner’s syndrome participating in a randomized dose–response study, Pediatr. Res., 50, 417, 10.1203\u002F00006450-200109000-00019\nNeely, 1993, Turner syndrome adolescents receiving growth hormone are not osteopenic, J. Clin. Endocrinol. Metab., 76, 861, 10.1210\u002Fjc.76.4.861\nShaw, 1997, Bone mineral density in Turner’s syndrome – a longitudinal study, Clin. Endocrinol. (Oxf.), 47, 367, 10.1046\u002Fj.1365-2265.1997.2791084.x\nCarrascosa, 2000, Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients, J. Bone Miner. Res., 15, 2005, 10.1359\u002Fjbmr.2000.15.10.2005\nSuganuma, 2003, Bone mineral density in adult patients with Turner’s syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies, Endocr. J., 50, 263, 10.1507\u002Fendocrj.50.263\nBakalov, 2003, Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency, J. Clin. Endocrinol. Metab., 88, 5717, 10.1210\u002Fjc.2003-030913\nBakalov, 2004, Growth hormone therapy and bone mineral density in Turner syndrome, J. Clin. Endocrinol. Metab., 89, 4886, 10.1210\u002Fjc.2004-0481\nOdvina, 2005, Severely suppressed bone turnover: a potential complication of alendronate therapy, J. Clin. Endocrinol. Metab., 90, 1294, 10.1210\u002Fjc.2004-0952",{"EN":1278},"Investigation of cardiac status and bone mineral density in Turner syndrome",{"VOID":1280},"10.1016\u002Fj.ghir.2006.03.008","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637406000347",[1283,1298],{"id":1284,"sortIndex":19,"researcher":18,"roles":1285,"affiliations":1286,"properties":1295},"331f08c1-7481-4bf2-a581-74aaa36fdbe4",[133],[1287],{"id":18,"sortIndex":19,"affiliation":1288,"properties":18},{"id":1289,"createTime":1290,"updateTime":1290,"relativeEntities":1291,"slug":18,"properties":1292,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"112138f1-3196-41e2-9c07-0aabaa6a24ec","2023-12-13T03:11:39.079+00:00",[],{"title":1293},{"VI":1294},"Developmental Endocrinology Branch, National Institute of Child Health and Human Development, CRC 1-3330, 10 Center Dr, National Institutes of Health, Bethesda, MD 20892, United States",{"title":1296},{"VI":1297},"Carolyn A. Bondy",{"id":1299,"sortIndex":104,"researcher":18,"roles":1300,"affiliations":1301,"properties":1307},"f4637492-9d4d-4146-9811-37c8837b93fe",[133],[1302],{"id":18,"sortIndex":19,"affiliation":1303,"properties":18},{"id":1289,"createTime":1290,"updateTime":1290,"relativeEntities":1304,"slug":18,"properties":1305,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1306},{"VI":1294},{"title":1308},{"VI":1309},"Vladimir K. Bakalov",{"url":1281,"publisher":1311,"properties":1338},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1312,"slug":10,"properties":1313,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1316,"manageAffiliations":1317,"indexDatabases":1318,"url":18,"thumbnailPath":18,"statistic":1333,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1314,"title":1315},{"VOID":13},{"EN":15},[],[],[1319,1326],{"id":83,"indexDatabase":1320,"url":96,"indexYears":97,"academicFieldIds":1325,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":1321,"label":1322,"description":1323,"key":93,"publicationTags":1324,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":1327,"url":78,"indexYears":18,"academicFieldIds":1332,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":1328,"label":1329,"description":1330,"key":74,"publicationTags":1331,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":1334,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":1335,"totalCitation":19,"totalCitationByYear":1336,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":1337,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":1339,"pages":1341},{"VOID":1340},"16",{"VOID":1342},"103-108","2006-07-01",2006,{"id":1346,"createTime":1347,"updateTime":1348,"relativeEntities":1349,"slug":1350,"properties":1351,"entityType":125,"verifyStatus":126,"verifyTime":1358,"verifyNote":127,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1359,"fullTextUrl":18,"authors":1360,"publicationType":158,"publisherRelationship":1418,"citationCount":18,"citationInfo":18,"publishDate":1450,"publishYear":1012,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":194},"6296180e-b2b0-40a1-b494-4799af15ef9c","2023-12-07T21:52:17.848+00:00","2025-02-25T23:34:05.433+00:00",[],"The-complex-of-recombinant-human-insulin-like-growth-factor-I-rhIGF-I-and-its-binding-protein-5-IGFBP-5-induces-local-bone-formation-in-murine-calvariae-and-in-rat-cortical-bone-after-local-or-systemic-administration",{"references":1352,"title":1354,"doi":1356},{"VOID":1353},"Bautista, 1990, Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates, Metabolism, 39, 96, 10.1016\u002F0026-0495(90)90154-5\nRosen, 1994, Insulin-like growth factors and bone: the osteoporosis connection, Proc Soc Exp Biol Med, 206, 83, 10.3181\u002F00379727-206-43726\nAndress, 1992, Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action, J Biol Chem, 267, 22467, 10.1016\u002FS0021-9258(18)41695-X\nHock, 1988, Insulin-like growth factor I has independent effects on bone matrix formation and cell replication, Endocrinology, 122, 254, 10.1210\u002Fendo-122-1-254\nAmman, 1995, IGF-I and pamidronate increase bone mineral density in ovariectomized rats, Am J Physiol, 265 (Endocrinol Metab 28), E770\nBagi, 1994, Benefit of systemically administered rhlGF-I and rhIGF-I\u002FIGFBP-3 on cancellous bone in ovariectomized rats, J Bone Miner Res, 9, 1301, 10.1002\u002Fjbmr.5650090820\nMachwate, 1994, Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats, Endocrinology, 134, 1031, 10.1210\u002Fendo.134.3.8119139\nSpencer, 1991, In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats, Bone, 12, 21, 10.1016\u002F8756-3282(91)90050-S\nBikle, 1994, Skeletal unloading induces resistance to insulin-like growth factor I, J Bone Miner Res, 9, 1789, 10.1002\u002Fjbmr.5650091116\nIbbotson, 1992, Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis, J Bone Miner Res, 7, 425, 10.1002\u002Fjbmr.5650070410\nTobias, 1992, Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats, Endocrinology, 131, 2387, 10.1210\u002Fendo.131.5.1425437\nClemmons, 1997, Insulin-like growth factor binding proteins and their role in controlling IGF actions, Cytokine Growth Factor Rev, 3, 45, 10.1016\u002FS1359-6101(96)00053-6\nRajaram, 1997, Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions, Endocr Rev, 18, 801\nAdams, 1995, Pharmacokinetics and bioavailability of rhIGF-I\u002FIGFBP-3 in the rat and monkey, Prog Growth Factor Res, 6, 347, 10.1016\u002F0955-2235(95)00003-8\nBautista, 1991, Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone, Biochem Biophys Res Commun, 76, 756, 10.1016\u002FS0006-291X(05)80249-9\nClemmons, 1992, Role of insulin-like growth factor binding proteins in modifying IGF actions, Ann NY Acad Sci, 692, 10, 10.1111\u002Fj.1749-6632.1993.tb26201.x\nJones, 1993, Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF I, J Cell Biol, 121, 679, 10.1083\u002Fjcb.121.3.679\nMohan, 1995, Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells, J Biol Chem, 270, 20 424, 10.1074\u002Fjbc.270.35.20424\nMohan, 1995, Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging, Prog Growth Factor Res, 6, 465, 10.1016\u002F0955-2235(95)00027-5\nRichman, 1999, Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo, Endocrinology, 140, 4699, 10.1210\u002Fendo.140.10.7081\nKalus, 1998, Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions, EMBO J, 17, 6558, 10.1093\u002Femboj\u002F17.22.6558\nMackie, 1990, Stimulation of bone formation in vivo by transforming growth factor-β: remodeling of woven bone and lack of inhibition by indomethacin, Bone, 11, 295, 10.1016\u002F8756-3282(90)90083-B\nHefti, 1980, Use of dermestid beetles for cleaning bones, Calcif Tissue Int, 31, 45, 10.1007\u002FBF02407166\nBauss, 1985, Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the rat, Calcif Tissue Int, 37, 539, 10.1007\u002FBF02557838\nYamazaki, 1989, Characteristics of an ovariectomized osteopenic rat model, J Bone Miner Res, 4, 13, 10.1002\u002Fjbmr.5650040104\nSchenk, R. K. Olah, A. J. Herrmann, W. Preparation of calcified tissue for light microscopy. Dickson, G, R, Methods of Calcified Tissue Preparation. Amsterdam, Elsevier, 1994, 1, 56.\nParfitt, 1987, Bone histomorphometry: standardization of nomenclature, symbols, and units, J Bone Miner Res, 2, 595, 10.1002\u002Fjbmr.5650020617\nAndress, 1995, Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells, J Biol Chem, 270, 28 289, 10.1074\u002Fjbc.270.47.28289\nAndress, 1998, Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor, Am J Physiol, 274 (Endocrinol Metab 37), E744\nRadulescu, 1994, Nuclear localization signal in insulin-like growth factor-binding protein type 3, Trends Biochem Sci, 19, 278, 10.1016\u002F0968-0004(94)90004-3\nSchedlich, 2000, Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin β subunit, J Biol Chem, 275, 23 462, 10.1074\u002Fjbc.M002208200\nCamacho-Hubner, 1992, Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion, J Biol Chem, 267, 11 949, 10.1016\u002FS0021-9258(19)49788-3\nHekeda, 1996, Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandine E2-treatment, J Cell Physiol, 166, 370, 10.1002\u002F(SICI)1097-4652(199602)166:2\u003C370::AID-JCP15>3.0.CO;2-F\nJames, 1996, Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism, J Cell Biol, 133, 683, 10.1083\u002Fjcb.133.3.683\nYeh, 1997, Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation, Endocrinol, 138, 4181, 10.1210\u002Fendo.138.10.5465\nReeve, 1995, Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts, J Biol Chem, 270, 135, 10.1074\u002Fjbc.270.1.135\nBagi, 1995, Treatment of ovariectomized rats with complex of rhIGF-I\u002FIGFBP-3 increases cortical and cancellous bone mass and improves structure in femoral neck, Calcif Tissue Int, 57, 40, 10.1007\u002FBF00298995\nBagi, 1995, Systemic administration of rhIGF-I or rhIGF-I\u002FIGFBP-3 increases cortical bone and lean body mass in ovariectomized rats, Bone, 16, 263S, 10.1016\u002FS8756-3282(95)80073-5\nMüller, 1994, Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats, Am J Physiol, 267 (Endocrinol Metab 30), E1\nWesterlind, 1997, Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain, Proc Natl Acad Sci USA, 94, 4199, 10.1073\u002Fpnas.94.8.4199",{"EN":1355},"The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration",{"VOID":1357},"10.1054\u002Fghir.2000.0181","2025-02-25T23:34:05.432+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1096637400901813",[1361,1376,1391,1403],{"id":1362,"sortIndex":283,"researcher":18,"roles":1363,"affiliations":1364,"properties":1373},"40a61af4-d8f5-4d01-af78-f184febc2876",[133],[1365],{"id":18,"sortIndex":19,"affiliation":1366,"properties":18},{"id":1367,"createTime":1368,"updateTime":1368,"relativeEntities":1369,"slug":18,"properties":1370,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"654ff8be-67a8-4dd2-a3ff-cf16c7fc3878","2023-12-07T21:52:10.777+00:00",[],{"title":1371},{"VI":1372},"Roche Diagnostics GmbH, Pharma Research, Bone Metabolism, Sandhofer Strasse 116, Mannheim, D-68305, Germany",{"title":1374},{"VI":1375},"L. Kling",{"id":1377,"sortIndex":104,"researcher":18,"roles":1378,"affiliations":1379,"properties":1388},"3b90e513-57bb-43aa-b6fc-c40f18ba8a4f",[133],[1380],{"id":18,"sortIndex":19,"affiliation":1381,"properties":18},{"id":1382,"createTime":1383,"updateTime":1383,"relativeEntities":1384,"slug":18,"properties":1385,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"d48c221e-f5d7-4793-939d-ec5a0298fdfe","2023-12-07T21:52:10.787+00:00",[],{"title":1386},{"VI":1387},"Am Nonnenwald 2, Penzberg, D-82372, Germany",{"title":1389},{"VI":1390},"K. Lang",{"id":1392,"sortIndex":19,"researcher":18,"roles":1393,"affiliations":1394,"properties":1400},"6df54edf-3518-4f6e-9986-44a274c2a43b",[133],[1395],{"id":18,"sortIndex":19,"affiliation":1396,"properties":18},{"id":1367,"createTime":1368,"updateTime":1368,"relativeEntities":1397,"slug":18,"properties":1398,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1399},{"VI":1372},{"title":1401},{"VI":1402},"F. Bauss",{"id":1404,"sortIndex":238,"researcher":18,"roles":1405,"affiliations":1406,"properties":1415},"6b6e1677-19cf-46ef-b1cc-d0ac41b1a7e8",[133],[1407],{"id":18,"sortIndex":19,"affiliation":1408,"properties":18},{"id":1409,"createTime":1410,"updateTime":1410,"relativeEntities":1411,"slug":18,"properties":1412,"entityType":47,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"dc9ebcbf-8a20-4a69-9016-8ba125dbc3e5","2023-12-07T21:52:10.799+00:00",[],{"title":1413},{"VI":1414},"formerly, 2 currently at Scil Technology Holding GmbH, Fraunhoferstrasse 15, Martinsried, D-82152, Germany",{"title":1416},{"VI":1417},"C. Dony",{"url":1359,"publisher":1419,"properties":1446},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1420,"slug":10,"properties":1421,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1424,"manageAffiliations":1425,"indexDatabases":1426,"url":18,"thumbnailPath":18,"statistic":1441,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1422,"title":1423},{"VOID":13},{"EN":15},[],[],[1427,1434],{"id":83,"indexDatabase":1428,"url":96,"indexYears":97,"academicFieldIds":1433,"indexDatabaseRanking":101},{"id":85,"createTime":86,"updateTime":87,"relativeEntities":1429,"label":1430,"description":1431,"key":93,"publicationTags":1432,"standard":18},[],{"EN":90,"VI":90},{"EN":90,"VI":92},[95],[99,100],{"id":63,"indexDatabase":1435,"url":78,"indexYears":18,"academicFieldIds":1440,"indexDatabaseRanking":18},{"id":65,"createTime":66,"updateTime":67,"relativeEntities":1436,"label":1437,"description":1438,"key":74,"publicationTags":1439,"standard":18},[],{"EN":70,"VI":70},{"VI":72,"EN":73},[76,77],[80,81],{"impactFactor":19,"impactFactorByYear":1442,"i10Index":19,"i10IndexLast5Year":19,"totalPublication":104,"totalPublicationByYear":1443,"totalCitation":19,"totalCitationByYear":1444,"totalCitationPerPublication":19,"totalCitationPerPublicationByYear":1445,"hindexLast5Year":19,"hindex":19},{},{"2001":104},{},{},{"volume":1447,"pages":1448},{"VOID":1008},{"VOID":1449},"1-9","2001-02-01"]